WO2002024793A1 - Method for applying polymeric lens coating - Google Patents

Method for applying polymeric lens coating Download PDF

Info

Publication number
WO2002024793A1
WO2002024793A1 PCT/US2001/023028 US0123028W WO0224793A1 WO 2002024793 A1 WO2002024793 A1 WO 2002024793A1 US 0123028 W US0123028 W US 0123028W WO 0224793 A1 WO0224793 A1 WO 0224793A1
Authority
WO
WIPO (PCT)
Prior art keywords
reactive
hydrophilic
polymer
monomers
lens
Prior art date
Application number
PCT/US2001/023028
Other languages
French (fr)
Inventor
Joseph A. Mcgee
Paul L. Valint, Jr.
James A. Bonafini, Jr.
Joseph C. Salamone
Original Assignee
Bausch & Lomb Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch & Lomb Incorporated filed Critical Bausch & Lomb Incorporated
Priority to JP2002529197A priority Critical patent/JP2004512866A/en
Priority to EP01961687A priority patent/EP1319037A1/en
Priority to MXPA03002322A priority patent/MXPA03002322A/en
Priority to KR1020037003878A priority patent/KR100766642B1/en
Priority to CNB01815946XA priority patent/CN1266197C/en
Priority to AU2001282933A priority patent/AU2001282933A1/en
Priority to BR0114212-7A priority patent/BR0114212A/en
Priority to CA002420861A priority patent/CA2420861C/en
Publication of WO2002024793A1 publication Critical patent/WO2002024793A1/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/34Macromolecular materials
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J7/00Chemical treatment or coating of shaped articles made of macromolecular substances
    • C08J7/04Coating
    • C08J7/0427Coating with only one layer of a composition containing a polymer binder
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J7/00Chemical treatment or coating of shaped articles made of macromolecular substances
    • C08J7/04Coating
    • C08J7/056Forming hydrophilic coatings
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
    • G02B1/041Lenses
    • G02B1/043Contact lenses

Definitions

  • the present invention is directed toward the surface treatment of medical devices such as contact lenses and medical implants.
  • the present invention is directed to a method of renewably modifying the surface of a medical device to increase its biocompatibility or hydrophilicity by coating the device with a hydrophilic polymer by reaction between reactive functionalities in the contact lens material and complementary reactive functionalities on the hydrophilic polymer.
  • the present invention is also directed to a contact lens or other medical device having such a surface coating.
  • Non-hydrogels do not absorb appreciable amounts of water, whereas hydrogels can absorb and retain water in an equilibrium state.
  • Hydrogels generally have a water content greater than about five weight percent and more commonly between about 10 to about 80 weight percent. Regardless of their water content, both non-hydrogel and hydrogel silicone contact lenses tend to have relatively hydrophobic, non-wettable surfaces.
  • the surface of a continuous-wear lens must be designed not only for comfort, but to avoid adverse reactions such as corneal edema, inflammation, or lymphocyte infiltration. Improved methods have accordingly been sought for modifying the surfaces of contact lenses, particularly high-Dk (highly oxygen permeable) lenses designed for continuous (overnight) wear.
  • U.S. Patent 5,344,701 discloses the attachment of oxazolinone or azlactone monomers to a substrate by means of plasma.
  • the invention has utility in the field of surface-mediated or catalyzed reactions for synthesis or site-specific separations, including affinity separation of biomolecules, diagnostic supports and enzyme membrane reactors.
  • the oxazolinone group is attached to a porous substrate apparently by reaction of the ethylenic unsaturation in the oxazolinone monomer with radicals formed by plasma on the substrate surface.
  • the substrate can be coated with monomers and reacted with plasma to form a cross-linked coating.
  • oxazolinone groups that have been attached to the surface can then be used to attach a biologically active material, for example, proteins, since the oxazolinone is attacked by amines, thiols, and alcohols.
  • a biologically active material for example, proteins
  • U.S. Patent No. 5,364,918 to Valint et al. and U.S. Patent No. 5,352,714 to Lai et al. disclose the use of oxazolinone monomers as internal wetting agents for contact lenses, which agents may migrate to the surface of the contact lens.
  • US Patent No. 5,804,318 to Pinchuk et al. discloses lubrifying coatings for reducing the coefficients of friction of surfaces on medical devices, including hydrophilic copolymers containing some monomers having pendant tertiary amine functionality.
  • the hydrogel coatings are covalently bondable to epoxy functionalized surfaces on the medical equipment.
  • US Patent No. 4,734,475 to Goldenberg et al. discloses the use of a contact lens fabricated from a polymer comprising oxirane (epoxy) substituted monomeric units in the backbone, such that the outer surfaces of the lens contain a hydrophilic inducing amount of the reaction product of the oxirane monomeric units with a water soluble reactive organic, amine, alcohol, thiol, urea, thiourea, sulfite, bisulfite or thiosulfate.
  • an optically clear, hydrophilic coating for the surface of a silicone medical device that renders the device more biocompatible. It would also be desirable to form a coating for a silicone hydrogel contact lens that is more comfortable for a longer period of time, simultaneously tear- wettable and highly permeable to oxygen. It would be desirable if such a biocompatibilized lens was capable of continuous wear overnight, preferably for a week or more without adverse effects to the cornea. Further, it would be desirable to provide a coating with these properties that can be readily renewed to restore its properties to an as-new state.
  • FIG. 1 shows an Atomic Force Microscopy (AFM) topographical image (50 ⁇ m 2 ) of a control contact lens described in Example 15 below, for comparison to a contact lenses according to the invention; the image of the anterior side of the lens is shown on the left of FIG. 1 and the image of the posterior side is shown on the right.
  • AFM Atomic Force Microscopy
  • FIG. 2 shows an Atomic Force Microscopy (AFM) topographical image (50 ⁇ m 2 ) of a contact lens coated described in Example 14 according to one embodiment of the present invention, which lens is a silicone rigid-gas-permeable lens coated with a polymer as described in Example 10, a copolymer of dimethyl acrylamide and glycidyl methacrylate.
  • AFM Atomic Force Microscopy
  • FIG. 3 shows an Atomic Force Microscopy (AFM) topographical image (50 ⁇ m 2 ) of a contact lens coated described in Example 15 according to one embodiment of the present invention, which lens is a silicone rigid-gas-permeable lens coated with a combination of the hydrophilic copolymers described in Examples 10 and Example 12.
  • AFM Atomic Force Microscopy
  • FIG. 4 shows Atomic Force Microscopy (AFM) topographical image (50 ⁇ m 2 ) of a control contact lens described in Example 16 for comparison to other lenses according to another embodiment of the present invention, which lens is a silicone hydrogel lens coated with a polymer as described in Example 11.
  • AFM Atomic Force Microscopy
  • FIG. 5 shows Atomic Force Microscopy (AFM) topographical image (50 ⁇ m 2 ) of a contact lens coated described in Example 16 according to one embodiment of the present invention, which lens is a silicone hydrogel lens coated with a polymer as described in Example 11, a copolymer of dimethyl acrylamide, glycidyl methacrylate, and octafluoropentylmethacrylate.
  • AFM Atomic Force Microscopy
  • FIG. 6 shows Atomic Force Microscopy (AFM) topographical image (50 ⁇ m 2 ) of a contact lens coated described in Example 16 according to one embodiment of the present invention, which lens is a silicone hydrogel lens coated with a polymer as described in Example 11, a copolymer of dimethyl acrylamide, glycidyl methacrylate, and octafluoropentylmethacrylate, which is used for coating at a higher concentration than was used for coating the lens in FIG. 5.
  • AFM Atomic Force Microscopy
  • FIG. 7 is an Atomic Force Microscopy (AFM) topographical image (50 ⁇ m 2 ) of an RGP contact lens material button of Example 18 prior to surface treatment.
  • AFM Atomic Force Microscopy
  • FIG. 8 is an Atomic Force Microscopy (AFM) topographical image (50 ⁇ m 2 ) of the surface of an RGP button after a first hydrophilic polymer coating step in Example 18.
  • AFM Atomic Force Microscopy
  • FIG. 9 is an Atomic Force Microscopy (AFM) topographical image (50 ⁇ m 2 ) of the surface of an RGP button after abrasive removal of the polymer coating in Example 18.
  • FIGJO is an Atomic Force Microscopy (AFM) topographical image (50 ⁇ m 2 ) of the surface of an RGP button after the hydrophilic polymeric surface was reapplied in Example 18.
  • the present invention is directed toward surface treatment of silicone contact lenses and other silicone medical devices, including a method of modifying the surface of a contact lens to increase its hydrophilicity or wettability.
  • the surface treatment comprises the attachment of hydrophilic polymer chains at reaction temperatures of less than 55°c to the surface of the contact lens substrate by means of reactive functionalities in the lens substrate material reacting with complementary reactive functionalities in monomeric units along a hydrophilic reactive polymer. Subsequently the hydrophiUc polymer chains can be removed from the contact lens substrate and then re-applied to achieve substantially as-new surface quality.
  • the term "as-new surface quality" means a re-applied surface resembling the original surface coating in appearance and material properties.
  • the reaction temperature is from 15 to about 45 °c, more preferably from about 20 to about 40°c, most preferably about ambient temperature.
  • the present invention is also directed to a medical device, examples of which include contact lenses, intraocular lenses, catheters, implants, and the like, comprising a surface made by such a method.
  • Examples of medical devices that can be fabricated in accordance with the present invention include dental appliances, including retainers and mouth guards, hearing aids, yarns for clothing or for orthopaedic or other medical/surgical implants and appliances such as punctal plugs, stents and braces.
  • the present invention is directed toward surface treatment of medical devices, including contact lenses, intraocular lenses and vascular implants, to improve their biocompatibility.
  • the present invention is especially advantageous for application to contact lenses, such as hydrogels, silicone hydrogels, and rigid-gas- permeable lens materials.
  • the invention is especially advantageous for silicone rigid- gas-permeable lenses.
  • rigid-gas-permeable (“RGP") materials and hydrogels are well-known classes of materials.
  • silicone it is meant that the material being treated is an organic polymer comprising at least five percent by weight silicone (-OSi- linkages), preferably 10 to 100 percent by weight silicone, more preferably 30 to 90 percent by weight silicone.
  • RGP materials typically comprise a hydrophobic cross-linked polymer system containing less than 5 wt. % water.
  • RGP materials useful in accordance with the present invention include those materials taught in US Patent No. 4,826,936 to Ellis; 4,463,149 to Ellis; 4,604,479 to Ellis; 4,686,267 to Ellis et al.; 4,826,936 to Ellis; 4,996,275 to Ellis et al.; 5,032,658 to Baron et al.; 5,070,215 to Bambury et al.; 5,177,165 to Valint et al.; 5,177,168 to Baron et al.; 5,219,965 to Valint et al.; 5,336,797 to McGee and Valint; 5,358,995 to Lai et al.; 5,364,918 to Valint et al.; 5,610,252 to Bambury et al.; 5,708,094 to Lai et al; and 5,98
  • Hydrogels comprise hydrated, cross-linked polymeric systems containing water in an equilibrium state. Silicone hydrogels generally have a water content greater than about five weight percent and more commonly between about ten to about eighty weight percent. Such materials are usually prepared by polymerizing a mixture containing at least one silicone-containing monomer and at least one hydrophilic monomer. Either the silicone-containing monomer or the hydrophilic monomer may function as a cross- linking agent (a cross-linker being defined as a monomer having multiple polymerizable functionalities) or a separate cross-linker may be employed. Applicable silicone- containing monomeric units for use in the formation of silicone hydrogels are well known in the art and numerous examples are provided in U.S. Patent Nos. 4,136,250; 4,153,641; 4,740,533; 5,034,461; 5,070,215; 5,260,000; 5,310,779; and 5,358,995.
  • Examples of applicable silicon-containing monomeric units include bulky polysiloxanylalkyl (meth)acrylic monomers.
  • An example of bulky polysiloxanylalkyl (meth)acrylic monomers is represented by the following Formula I: wherein:
  • X denotes -O- or -NR-; each R 18 independently denotes hydrogen or methyl; each R 19 independently denotes a lower alkyl radical, phenyl radical or a group represented by
  • each R 19 independently denotes a lower alkyl or phenyl radical; and h is 1 to 10.
  • Some preferred bulky monomers are methacryloxypropyl tris(trimethyl- siloxy)silane or tris(trimethylsiloxy)silylpropyl methacrylate, sometimes referred to as TRIS and tris(trimethylsiloxy)silylpropyl vinyl carbamate, sometimes referred to as TRIS-VC.
  • Such bulky monomers may be copolymerized with a silicone macromonomer, which is a poly(organosiloxane) capped with an unsaturated group at two or more ends of the molecule.
  • a silicone macromonomer which is a poly(organosiloxane) capped with an unsaturated group at two or more ends of the molecule.
  • U.S. Patent No. 4,153,641 to Deichert et al. discloses, for example, various unsaturated groups, including acryloxy or methacryloxy.
  • silicone-containing monomers includes silicone- containing vinyl carbonate or vinyl carbamate monomers such as: l,3-bis[4- vinyloxycarbonyloxy)but-l-yl]tetramethyl-disiloxane; 3-(trimethylsilyl)propyl vinyl carbonate; 3-(vinyloxycarbonylthio)propyl-[tris(trimethylsiloxy)silane]; 3-[tris(tri- methylsiloxy)silyl] propyl vinyl carbamate; 3-[tris(trimethylsiloxy)silyl] propyl allyl carbamate; 3-[tris(trimethylsiloxy)silyl]propyl vinyl carbonate; t- butyldimethylsiloxyethyl vinyl carbonate; trimethylsilylethyl vinyl carbonate; and trimethylsilylmethyl vinyl carbonate.
  • silicone- containing vinyl carbonate or vinyl carbamate monomers such as: l,3-bis[4- vinyloxycarbonyloxy)
  • silicon-containing monomers includes polyurethane- polysiloxane macromonomers (also sometimes referred to as prepolymers), that may have hard-soft-hard blocks like traditional urethane elastomers.
  • silicone urethanes are disclosed in a variety or publications, including Lai, Yu-Chin, "The Role of Bulky Polysiloxanylalkyl Methacryates in Polyurethane-Polysiloxane Hydrogels, " Journal of Applied Polymer Science, Vol. 60, 1193-1199 (1996).
  • PCT Published Application No. WO 96/31792 and US Patents No. 5,451,617 and 5,451,651 disclose examples of such monomers, which disclosures are hereby incorporated by reference in their entirety.
  • Further examples of silicone urethane monomers are represented by Formulae ⁇ and DI:
  • D denotes an alkyl diradical, an alkyl cycloalkyl diradical, a cycloalkyl diradical, an aryl diradical or an alkylaryl diradical having 6 to 30 carbon atoms;
  • G denotes an alkyl diradical, a cycloalkyl diradical, an alkyl cycloalkyl diradical, an aryl diradical or an alkylaryl diradical having 1 to 40 carbon atoms and which may contain ether, thio or amine linkages in the main chain;
  • * denotes a urethane or ureido linkage; a is at least 1;
  • A denotes a divalent polymeric radical of Formula IN: ⁇
  • each Rs independently denotes an alkyl or fluoro-substituted alkyl group having 1 to 10 carbon atoms which may contain ether linkages between carbon atoms; m' is at least 1; and p is a number that provides a moiety weight of 400 to 10,000; each of E and E' independently denotes a polymerizable unsaturated organic radical represented by Formula VI:
  • R 23 is hydrogen or methyl
  • R 24 is hydrogen, an alkyl radical having 1 to 6 carbon atoms, or a -CO-Y-R 26 radical wherein Y is -O-, -S- or - ⁇ H-;
  • R 25 is a divalent alkylene radical having 1 to 10 carbon atoms
  • R 26 is a alkyl radical having 1 to 12 carbon atoms
  • X denotes -CO- or -OCO-
  • Z denotes -O- or -NH-
  • Ar denotes an aromatic radical having 6 to 30 carbon atoms; w is 0 to 6; x is 0 or 1; y is 0 or 1; and z is 0 or 1.
  • a preferred silicone-containing urethane monomer is represented by Formula
  • m is at least 1 and is preferably 3 or 4
  • a is at least 1 and preferably is 1
  • p is a number which provides a moiety weight of 400 to 10,000 and is preferably at least 30
  • R 27 is a diradical of a diisocyanate after removal of the isocyanate group, such as the diradical of isophorone diisocyanate
  • each E" is a group represented by:
  • silicone-containing monomers includes fluorinated monomers. Such monomers have been used in the formation of fluorosilicone hydrogels to reduce the accumulation of deposits on contact lenses made therefrom, as described in U.S. Patent Nos. 4,954,587, 5,079,319 and 5,010,141.
  • silicone-containing monomers having certain fluorinated side groups, i.e. -(CF 2 )-H, have been found to improve compatibility between the hydrophilic and silicone- containing monomeric units, as described in U.S. Patent Nos. 5,387,662 and 5,321,108.
  • a silicone hydrogel material comprises (in bulk, that is, in the monomer mixture that is copolymerized) 5 to 50 percent, preferably 10 to 25, by weight of one or more silicone macromonomers, 5 to 75 percent, preferably 30 to 60 percent, by weight of one or more polysiloxanylalkyl (meth)acrylic monomers, and 10 to 50 percent, preferably 20 to 40 percent, by weight of a hydrophilic monomer.
  • hydrophilic monomers include, but are not limited to, ethylenically unsaturated lactam-containing monomers such as N-vinyl pyrrolidinone, methacrylic and acrylic acids; acrylic substituted alcohols, such as 2- hydroxyethylmethacrylate and 2-hydroxyethylacrylate and acrylamides, such as methacrylamide and N,N-dimethylacrylamide, vinyl carbonate or vinyl carbamate monomers such as disclosed in U.S. Patent Nos. 5,070,215, and oxazolinone monomers such as disclosed in U.S. Patent No. 4,910,277.
  • lactam-containing monomers such as N-vinyl pyrrolidinone, methacrylic and acrylic acids
  • acrylic substituted alcohols such as 2- hydroxyethylmethacrylate and 2-hydroxyethylacrylate and acrylamides, such as methacrylamide and N,N-dimethylacrylamide
  • vinyl carbonate or vinyl carbamate monomers such
  • hydrophilic monomers such as N,N-dimethyl acrylamide (DMA), 2-hydroxyethyl methacrylate (HEMA), glycerol methacrylate, 2-hydroxyethyl methacrylamide, polyethyleneglycol, monomethacrylate, methacrylic acid and acrylic acid are also useful in the present invention.
  • DMA N,N-dimethyl acrylamide
  • HEMA 2-hydroxyethyl methacrylate
  • glycerol methacrylate 2-hydroxyethyl methacrylamide
  • polyethyleneglycol monomethacrylate
  • methacrylic acid and acrylic acid acrylic acid
  • silicone materials are merely exemplary, and other materials for use as substrates that can benefit by being coated according to the present invention have been disclosed in various publications and are being continuously developed for use in contact lenses and other medical devices.
  • the present invention is directed to the modification of the surface of a medical device such as a contact lens by means of removably attaching to the surface hydrophilic polymer chains.
  • removably attaching refers to creating a chemical bond between the substrate material and the hydrophilic polymer chains which can be severed without substantial mechanical damage to the substrate
  • the hydrophilic polymer chains of the invention can be chemically or mechanically removed from the substrate material, for example by abrasion. Suitable mechanical means include high shear fluidic treatments such as a high speed fluid jet, as well as contacting the surface with a fluidized abrasive solid.
  • the hydrophilic polymeric surface coating may also be mechanically removed by grinding or polishing.
  • the preferred mechanical method for removing the polymeric surface coating of the invention from contact lenses is rubbing the contact lens with a commercially available abrasive cleaner containing an abrasive such as silica or aluminum oxide together with one or more of an anionic surfactant (such as an alkyl ether sulfonate), a nonionic surfactant (such as an ethoxylated alkyl phenol) and a cationic surfactant (such as a quaternary ammonium salt).
  • an anionic surfactant such as an alkyl ether sulfonate
  • a nonionic surfactant such as an ethoxylated alkyl phenol
  • a cationic surfactant such as a quaternary ammonium salt.
  • Particularly preferred abrasive cleaners include Boston ® and Boston Advanced ® brand abrasive cleaners, commercially available from Bausch & Lomb, Rochester, NY, 14604.
  • Suitable chemical means for removing the hydrophilic polymeric surface coating include oxidation, for example oxidative plasma, ozonation or corona discharge.
  • Other chemical means include chemical hydrolysis, hydrolytic cleavage or enzymatic removal.
  • hydrophihc polymer chains are attached to the surface by means of exposing the surface to hydrophihc reactive polymers (inclusive of oligomers) having ring- opening or isocyanate reactive functionalities complementary to reactive groups on the surface of the medical device.
  • the hydrophihc polymer chains may be attached to the surface by means of exposing the surface to hydrophilic reactive polymers (inclusive of oligomers) having hydroxy or (primary or secondary) amine groups complementary to azlactone reactive groups in the silicone material or having carboxylic acid complementary groups complementary to epoxy reactive groups in the silicone material.
  • chemical functionality at the surface of the medical device is utilized to covalently attach hydrophilic polymers to the object or substrate.
  • the hydrophihc reactive polymers may be homopolymers or copolymers comprising reactive monomeric units that contain either an isocyanate or a ring-opening reactive functionality optionally. Although these reactive monomeric units may also be hydrophilic, the hydrophilic reactive polymer may also be a copolymer of reactive monomeric units copolymerized with one or more of various non-reactive hydrophilic monomeric units. Lesser amounts of hydrophobic monomeric units may optionally be present in the hydrophilic polymer.
  • the ring-opening monomers include azlactone- functional, epoxy-functional and acid-anhydride-functional monomers.
  • hydrophilic reactive polymers may be employed.
  • the hydrophilic polymer chains attached to the substrate may be the result of the reaction of a mixture of polymers comprising (a) a first hydrophilic reactive polymer having reactive functionalities in monomeric units along the hydrophihc polymers complementary to reactive functionalities on the substrate surface and, in addition, (b) a second hydrophihc reactive polymer having supplemental reactive functionalities that are reactive with the first hydrophilic reactive polymer.
  • a mixture comprising an epoxy-functional polymer with an acid-functional polymer, either simultaneously or sequentially applied to the substrate to be coated have been found to provide relatively thick coatings. Utilizing a mixture of reactive polymers provides a means to further adjust the surface chemistry of a substrate material.
  • the hydrophilic reactive polymers comprise 1 to 100 mole percent of reactive monomeric units, more preferably 5 to 50 mole percent, most preferably 10 to40 mole percent.
  • the polymers may comprise 0 to 99 mole percent of non-reactive hydrophilic monomeric units, preferably 50 to 95 mole percent, more preferably 60 to 90 mole percent (the reactive monomers, once reacted may also be hydrophilic, but are by definition mutually exclusive with the monomers referred to as hydrophilic monomers which are non-reactive).
  • the weight average molecular weight of the hydrophihc reactive polymer may suitably range from about 200 to 1,000,000, preferably from about 1,000 to 500,000, most preferably from about 5,000 to 100,000.
  • Hydrophilic monomers may be aprotic types such as acrylamides (N,N- dimethylacrylamide, DMA), lactams such as N-vinylpyrrolidinone, and poly(alkylene oxides) such as methoxypolyoxyethylene methacrylates or may be protic types such as methacrylic acid or hydroxyalkyl (meth)acrylates such as hydroxyethyl (meth)acrylate.
  • DMA acrylamides
  • lactams such as N-vinylpyrrolidinone
  • poly(alkylene oxides) such as methoxypolyoxyethylene methacrylates
  • protic types such as methacrylic acid or hydroxyalkyl (meth)acrylates such as hydroxyethyl (meth)acrylate.
  • Hydrophilic monomers may also include anionic surfactants such as sodium acrylamido- 2-methylpropylsulfonate (AMPS) and zwitterions such as N,N-dimethyl-N- memacryloxyemyl-N-(3-sulfopropyl)-ammonium betain (SPE) and N,N-dimethyl-N- memacrylamidopropyl-N-(3-sulfopropyl)-ammonium betain (SPP).
  • anionic surfactants such as sodium acrylamido- 2-methylpropylsulfonate (AMPS) and zwitterions such as N,N-dimethyl-N- memacryloxyemyl-N-(3-sulfopropyl)-ammonium betain (SPE) and N,N-dimethyl-N- memacrylamidopropyl-N-(3-sulfopropyl)-ammonium betain (SPP).
  • Monomeric units which are hydrophobic optionally may be used in amounts up to 35 mole percent, preferably 0 to 20 mole percent, most preferably 0 to 10 mole percent.
  • hydrophobic monomers are alkyl methacrylate, fluorinated alkyl methacrylates, long-chain acrylamides such as octyl acrylamide, and the like.
  • the hydrophilic reactive polymer may comprise reactive monomeric units derived from azlactone-functional, epoxy-functional and acid- anhydride-functional monomers.
  • an epoxy-functional hydrophilic reactive polymer for coating a lens can be a copolymer contaimng glycidyl methacrylate (GMA) monomeric units, which will react, for example, with a lens substrate comprising carboxylic acid groups.
  • GMA glycidyl methacrylate
  • Preferred examples of anhydride-functional hydrophilic reactive polymers comprise monomeric units derived from monomers such as maleic anhydride and itaconic anhydride.
  • epoxy-functional reactive groups or arihyc de-functional reactive groups in the hydrophilic reactive polymer react with carboxylic (-COOH), alcohol (-OH), primary amine (-NH 2 ) groups or thiol groups (-SH) in the substrate, for example, substrates made from polymers comprising as monomeric umts from methacrylic acid (MAA), hydroxyalkylmethacrylates such as hydroxyethylmethacrylate (HEMA), or aminoalkyl methacrylates such as aminopropylmethacrylate, all common and commercially available monomers.
  • a catalyst such as 4- dime ylaminopyridine may be used to speed the reaction at room temperature, as will be understood by the skilled chemist.
  • Acidic groups may also be created in the substrate by the use of azlactone monomeric units that are hydrolyzed to the acid. These acid groups can be reacted with an epoxy or anhydride group in the hydrophilic reactive polymer. See, for example, US Patent No. 5,364,918 to Valint et al., herein incorporated by reference in its entirety, for examples of such substrates.
  • azlactone or isocyanate-functional groups in the hydrophilic reactive polymers may similarly react with amines or alcohols in the polymer substrate, reactions involving an alcohol preferably in the presence of a catalyst.
  • carboxylic acids, amines and hydrolyzed azlactones in the hydrophilic reactive polymers may react with epoxy-groups in the substrate, for example, the monomeric units described in US Patent No. 4,734,475 to Goldenberg et al., herein incorporated by reference in its entirety.
  • preformed (non-polymerizable) hydrophilic polymers containing repeat units derived from at least one ring-opening monomer, an isocyanate-containing monomer, an amine-containing monomer, a hydroxy-containing monomer, or a carboxylic containing monomer are reacted with reactive groups on the surface of the medical device such as a contact lens substrate.
  • the hydrophilic reactive polymers are attached to the substrate at one or more places along the chain of the polymer. After attachment, any unreacted reactive functionalities in the hydrophilic reactive polymer may be hydrolyzed to a non-reactive moiety, hi the case of epoxy, isocyanate or ring-opening monomeric units.
  • Suitable hydrophilic non-reactive monomers for comprising the hydrophilic reactive polymers include generally water soluble conventional vinyl monomers such as 2-hydroxyethyl-; 2- and 3-hydroxypropyl-; 2,3-dihydroxypropyl-; polyethoxyethyl-; and polyethoxypropylacrylates, methacrylates, acrylamides and methacrylamides; acrylamide, methacrylamide, N-methylacrylamide, N-methylmemacrylamide, N, N- dimethylacrylamide, N, N-dimethylmethacrylamide, N, N- dimethyl- and N, N-diethyl- aminoethyl acrylate and methacrylate and the corresponding acrylamides and methacrylamides; 2-and 4-vinylpyridine; 4-and 2-methyl-5-vinylpyridine; N-methyl-4- vinylpiperidine; 2-metfayl-l-vinylimidazole; N,-N-dime ylallylarnine; dimemyla
  • non-reactive monomers include generally water soluble conventional vinyl monomers such as acrylates and methacrylates of the general structure
  • R-2 H 2 C C— COOR3
  • R 2 is hydrogen or methyl and R 3 is hydrogen or is an aliphatic hydrocarbon group of up to 10 carbon atoms substituted by one or more water solubilizing groups such as carboxy, hydroxy, a ino, lower alltylamino, lower dialkyamino, a polyethylene oxide group with from 2 to about 100 repeating units, or substituted by one or more sulfate, phosphate, sulfonate, phosphonate, carboxamido, sulfonamido or phosphonamido groups, or mixtures thereof;
  • R 3 is an oligomer or polymer such as polyethylene glycol, polypropylene glycol, ⁇ oly(ethylene-propylene) glycol, poly(hydroxyethyl methacrylate), poly(dimethyl acrylamide), ⁇ oly(acrylic acid), poly(methacrylic acid), polysulfone, poly(vinyl alcohol), polyacrylamide, poly(acryl
  • R 4 is lower alkyl of 1 to 3 carbon atoms and R 2 is as defined above;
  • R 3 is as defined above;
  • R 3 OOCH CHCOOR 3 wherein R 3 is as defined above;
  • R 2 is as defined above and R 3 is as defined above with the proviso that R 3 is other than hydrogen; and vinyl substituted heterocycles, such as vinyl pyridines, piperidines and imidazoles and N- vinyl lactams, such as N-vinyl-2-pyrrolidone.
  • vinyl substituted heterocycles such as vinyl pyridines, piperidines and imidazoles and N- vinyl lactams, such as N-vinyl-2-pyrrolidone.
  • water soluble monomers include acrylic and methacrylic acid; itaconic, crotonic, fumaric and maleic acids and the lower hydroxyalkyl mono and diesters thereof, such as the 2-hydroxethyl fumarate and maleate, sodium acrylate and methacrylate; 2-methacryloyloxyethylsulfonic acid and allylsulfonic acid.
  • hydrophobic monomers may provide the benefit of causing the formation of tiny dispersed polymer aggregates in solution, evidenced by a haziness in the solution of the polymer. Such aggregates can also be observed in Atomic Force Microscopy images of the coated medical device.
  • Suitable hydrophobic copolymerizable monomers include water insoluble conventional vinyl monomers such as acrylates and methacrylates of the general formula:
  • R 2 is as defined above and R 5 is a straight chain or branched aliphatic, cycloaliphatic or aromatic group having up to 20 carbon atoms which is unsubstituted or substituted by one or more alkoxy, alkanoyloxy or alkyl of up to 12 carbon atoms, or by halo, especially chloro or preferably fluoro, C2 to C5 polyalkyleneoxy of 2 to about 100 units, or an oligomer such as polyethylene, poly(methyl methacrylate), poly(ethyl methacrylate), or poly(glycidyl methacrylate), mixtures thereof, and copolymers thereof; acrylamides and methacylamides of the general formula:
  • R j is as defined above; itaconates of the formula:
  • R j is as defined above; and vinylic substituted hydrocarbons of the formula:
  • R 2 and Rj is as defined above
  • Useful or suitable hydrophobic monomers include, for example: methyl, ethyl, propyl, isopropyl, butyl, ethoxyethyl, methoxyethyl, ethoxypropyl, phenyl, benzyl, cyclohexyl, hexafluoroisopropyl, or n-octyl-acrylates and -methacrylates as well as the corresponding acrylamides and methacrylamides; dimethyl fumarate, dimethyl itaconate, dimethyl maleate, diethyl fumarate, methyl vinyl ether, ethoxyethyl vinyl ether, vinyl acetate, vinyl propionate, vinyl benzoate, acrylonitrile, styrene, alpha-methylstyrene, 1- hexene, vinyl chloride, vinyl methylketone, vinyl stearate, 2-hexene and 2-ethylhexyl methacrylate.
  • the hydrophihc reactive polymers are synthesized in a manner known per se from the corresponding monomers (the term monomer here also including a macromer) by a polymerization reaction customary to the person skilled in the art.
  • the hydrophihc reactive polymers or chains are formed by: (1) mixing the monomers together; (2) adding a polymerization initiator; (3) subjecting the monomer/initiator mixture to a source of ultraviolet or actinic radiation and/or elevated temperature and curing said mixture.
  • Typical polymerization initiators include free-radical-generating polymerization initiators of the type illustrated by acetyl peroxide, lauroyl peroxide, decanoyl peroxide, coprylyl peroxide, benzoyl peroxide, tertiary butyl peroxypivalate, sodium percarbonate, tertiary butyl peroctoate, and azobis-isobutyronitrile (ATBN).
  • Ultraviolet free-radical initiators illustrated by diethoxyacetophenone can also be used. The curing process will of course depend upon the initiator used and the physical characteristics of the comonomer mixture such as viscosity. In any event, the level of initiator employed will vary within the range of 0.001 to 2 weight percent of the mixture of monomers. Usually, a mixture of the above-mentioned monomers is warmed with addition of a free-radical former.
  • a polymerization to form the hydrophilic reactive polymer can be carried out in the presence or absence of a solvent.
  • Suitable solvents are in principle all solvents which dissolve the monomer used, for example water; alcohols such as lower alkanols, for example, ethanol and methanol; carboxamides such as dimethylformamide, dipolar aprotic solvents such as dimethyl sulfoxide or methyl ethyl ketone; ketones such as acetone or cyclohexanone; hydrocarbons such as toluene; ethers such as THF, dimethoxyethane or dioxane; halogenated hydrocarbons such as trichloroethane, and also mixtures of suitable solvents, for example mixtures of water and an alcohol, for example a water/ethanol or water/methanol mixture.
  • the contact lens or other medical device may be exposed to hydrophilic reactive polymers by immersing the substrate in a solution containing the polymers.
  • a contact lens may be placed or dipped for a suitable period of time in a solution of the hydrophilic reactive polymer or copolymer in a suitable medium, for example, an aprotic solvent such as acetonitrile.
  • the reaction temperature must be at least sufficient to maintain the reactants in liquid solution and is suitably less than 55°c.
  • the reaction temperature is preferably from about 15 to about 45°c, more preferably from about 20 to about 40° c, and most preferably is approximately ambient temperature.
  • one embodiment of the invention involves the attachment of reactive hydrophilic polymers to a medical device, which polymers comprise isocyanate- containing monomeric units or ring-opening monomeric units.
  • the ring-opening reactive monomer has an azlactone group represented by the following formula:
  • R 3 and R 4 independently can be an alkyl group having 1 to 14 carbon atoms, a cycloalkyl group having 3 to 14 carbon atoms, an aryl group having 5 to 12 ring atoms, an arenyl group having 6 to 26 carbon atoms, and 0 to 3 heteroatoms non-peroxidic selected from S, N, and O, or R 3 and R taken together with the carbon to which they are joined can form a carbocyclic ring containing 4 to 12 ring atoms, and n is an integer 0 or 1.
  • Such monomeric units are disclosed in U.S. Patent No. 5,177,165 to Valint et al.
  • the ring structure of such reactive functionalities is susceptible to nucleophi ⁇ c ring-opening reactions with complementary reactive functional groups on the surface of the substrate being treated.
  • the azlactone functionality can react with primary amines, hydroxyls, or thiols in the substrate, as mentioned above, to form a covalent bond between the substrate and the hydrophilic reactive polymer at one or more locations along the polymer.
  • a plurality of attachments can form a series of polymer loops on the substrate, wherein each loop comprises a hydrophilic chain attached at both ends to the substrate.
  • Azlactone-functional monomers for making the hydrophilic reactive polymer can be any monomer, prepolymer, or oligomer comprising an azlactone functionality of the above formula in combination with a vinylic group on an unsaturated hydrocarbon to which the azlactone is attached.
  • azlactone-functionality is provided in the hydrophilic polymer by 2-alkenyl azlactone monomers.
  • the 2-alkenyl azlactone monomers are known compounds, their synthesis being described, for example, in U.S. Patent. Nos. 4,304,705; 5,081,197; and 5,091,489 (all Heilmann et al.) the disclosures of which are incorporated herein by reference.
  • Suitable 2-alkenyl azlactones include:
  • the azlactone monomers are a compound represented by the
  • R and R ⁇ independently denote a hydrogen atom or a lower alkyl radical with one to six carbon atoms
  • R ⁇ and R ⁇ independently denote alkyl radicals with one to six carbon atoms or a cycloalkyl radical with five or six carbon atoms.
  • TPDMO 2-isopropenyl-4,4-dimethyl-2-oxazolin-5-one
  • VDMO 2-vinyl-4,4-dimethyl-2-oxazolin-5-one
  • TPCO 2-isopropenyl-4,4-dimethyl-2-oxazolin-5-one
  • PDMO 2-(-l-propenyl)-4,4-dimethyl-oxazol-5-one
  • the first step is a Shotten-Bauman acylation of an amino acid.
  • the polymerizable functionality is introduced by using either acryloyl or methacryloyl chloride.
  • the second step involves a ring closure with a chloroformate to yield the desired oxazolinone.
  • the product is isolated and purified by the usual procedures of organic chemistry.
  • the compounds can be copolymerized with hydrophilic and or hydrophobic comonomers to form hydrophihc reactive polymers. After attachment to the desired substrate, any unreacted oxazolinone groups may then be hydrolyzed in order to convert the oxazolinone components into amino acids.
  • the hydrolysis step will follow the general reaction of:
  • Non-limiting examples of comonomers useful to be copolymerized with azlactone functional moieties to form the hydrophilic reactive polymers used to coat a medical device include those mentioned above, preferably dimethylacrylamide, N-vinyl pyrrolidinone. Further examples of comonomers are disclosed in European Patent Publication 0 392 735, the disclosure of which is incorporated by reference. Preferably, dimethylacrylamide is used as a comonomer in order to impart hydrophihcity to the copolymer.
  • Such azlactone-functional monomers can be copolymerized with other monomers in various combinations of weight percentages. Using a monomer of similar reactivity ratio to that of an azlactone monomer will result in a random copolymer. Determination of reactivity ratios for copolymerization are disclosed in Odian, Principles of Polymerization, 2nd Ed., John Wiley & Sons, p. 425-430 (1981), the disclosure of which is incorporated by reference herein. Alternatively, use of a comonomer having a higher reactivity to that of an azlactone will tend to result in a block copolymer chain with a higher concentration of azlactone-functionality near the terminus of the chain.
  • azlactone-functional prepolymers or oligomers having at least one free-radically polymerizable site can also be utilized for providing azlactone-functionality in the hydrophilic reactive polymer according to the present invention.
  • Azlactone-functional oligomers for example, are prepared by free radical polymerization of azlactone monomers, optionally with comonomers as described in U.S. Patent Nos. 4,378,411 and 4,695,608, incorporated by reference herein.
  • Non- limiting examples of azlactone-functional oligomers and prepolymers are disclosed in U.S. Pat. Nos. 4,485,236 and 5,081,197 and European Patent Publication 0 392 735, all incorporated by reference herein.
  • the ring-opening reactive group in the hydrophilic reactive polymer is an epoxy functionality.
  • the preferred epoxy-functional monomer is an oxfr ane-containing monomer such as glycidyl methacrylate, allyl glycidyl ether, 4-vinyl-l-cyclohexene-l,2-epoxide and the like, although other epoxy-containing monomers may be used.
  • the hydrophilic reactive polymers are attached to medical devices which may be made by conventional manufacturing processes.
  • contact lenses for application of the present invention can be manufactured employing various conventional techniques, to yield a shaped article having the desired posterior and anterior lens surfaces.
  • Spincasting methods are disclosed in U.S. Patent Nos. 3,408,429 and 3,660,545; preferred static casting methods are disclosed in U.S. Patent Nos. 4,113,224 and 4,197,266. Curing of the monomeric mixture is often followed by a machining operation in order to provide a contact lens having a desired final configuration.
  • 4,555,732 discloses a process in which an excess of a monomeric mixture is cured by spincasting in a mold to form a shaped article having an anterior lens surface and a relatively large thickness.
  • the posterior surface of the cured spincast article is subsequently lathe cut to provide a contact lens having the desired thickness and posterior lens surface. Further machining operations may follow the lathe cutting of the lens surface, for example, edge-finishing operations. After producing a lens having the desired final shape, it is desirable to remove residual solvent from the lens before edge-finishing operations.
  • an organic diluent is included in the initial monomeric mixture in order to minimize phase separation of polymerized products produced by polymerization of the monomeric mixture and to lower the glass transition temperature of the reacting polymeric mixture, which allows for a more efficient curing process and ultimately results in a more uniformly polymerized product.
  • Sufficient uniformity of the initial monomeric mixture and the polymerized product are of particular concern for silicone hydrogels, primarily due to the inclusion of silicone-containing monomers which may tend to separate from the hydrophilic comonomer.
  • Suitable organic diluents include, for example, 2-hydoxy, 2-methyl decane, monohydric alcohols, with C -C 10 straight-chained or branched alcohols including aliphatic monohydric alcohols such as n-hexanol and n- nonanol being especially preferred.
  • US Patent 6,020,445 to Vanderlaan et al. discloses suitable alcohols and is incorporated herein by reference.
  • organic diluent is sufficiently volatile to facilitate its removal from a cured article by evaporation at or near ambient pressure.
  • the diluent is included at five to sixty percent by weight of the monomeric mixture, with ten to fifty percent by weight being especially preferred.
  • the cured lens is then subjected to solvent removal, which can be accomplished by evaporation at or near ambient pressure or under vacuum.
  • An elevated temperature can be employed to shorten the time necessary to evaporate the diluent.
  • the time, temperature and pressure conditions for the solvent removal step will vary depending on such factors as the volatility of the diluent and the specific monomeric components, as can be readily determined by one skilled in the art.
  • the temperature employed in the removal step is preferably at least 50°C, for example, 60 to 80 °C.
  • a series of heating cycles in a linear oven under inert gas or vacuum may be used to optimize the efficiency of the solvent removal.
  • the cured article after the diluent removal step should contain no more than twenty percent by weight of diluent, preferably no more than five percent by weight or less.
  • the lens is next subjected to mold release and optional machining operations.
  • the machining step includes, for example, buffing or polishing a lens edge and/or surface.
  • machining processes may be performed before or after the article is released from a mold part.
  • the lens is dry released from the mold by employing vacuum tweezers to lift the lens from the mold, after which the lens is transferred by means of mechanical tweezers to a second set of vacuum tweezers and placed against a rotating surface to smooth the surface or edges. The lens may then be turned over in order to machine the other side of the lens.
  • the lens is subjected to surface treatment according to the present invention, as described above, including the attachment of the hydrophilic reactive polymer chains.
  • the lens may be subjected to extraction to remove residuals in the lenses.
  • some of the monomer mix is not fully polymerized.
  • the incompletely polymerized material from the polymerization process may affect optical clarity or may be harmful to the eye.
  • Residual material may include solvents not entirely removed by the previous solvent removal operation, unreacted monomers from the monomeric mixture, oligomers present as by-products from the polymerization process, or even additives that may have migrated from the mold used to form the lens.
  • the lens is subjected to hydration in which the lens is fully hydrated with water, buffered saline, or the like.
  • the coating remains intact and bound to the lens, providing a durable, hydrophihc coating which has been found to be resistant to delamination.
  • the lens may undergo cosmetic inspection wherein trained inspectors inspect the contact lenses for clarity and the absence of defects such as holes, particles, bubbles, nicks, tears. Inspection is preferably at 10X magnification.
  • the lens is ready for packaging, whether in a vial, plastic blister package, or other container for maintaining the lens in a sterile condition for the consumer.
  • the packaged lens is subjected to sterilization, which sterilization may be accomplished in a conventional autoclave, preferably under an air pressurization sterilization cycle, sometime referred to as an air-steam mixture cycle, as will be appreciated by the skilled artisan.
  • the autoclaving is at 100° C to 200° C for a period of 10 to 120 minutes.
  • the lens dimension of the sterilized lenses may be checked prior to storage.
  • RGP rigid-gas-permeable
  • examples of rigid-gas-permeable (“RGP") materials useful in the present invention include the materials prepared from sihcone-containing monomers as taught in US Patent Nos. 4,152,508; 4,330,383; 4,686,267; 4,826,889; 4,826,936; 4,861,850; 4,996,275; and 5,346,976.
  • the teachings of these patents are expressly incorporated herein by reference.
  • the RGP materials do not generally require solvent removal or extraction steps before they are used as substrates in accordance with the invention.
  • EXAMPLE 1 This example discloses a representative silicone hydrogelJens material used as a coating substrate in the following Examples. The formulation for the material is provided in Table 1 below.
  • N 2 D 25 a silicone-containing vinyl carbonate as previously described in U.S. Patent No. 5,534,604.
  • EXAMPLE 2 This Example illustrates a process for preparation of a contact lens prior to surface modification of a contact lens according to the present invention.
  • Silicone hydrogel lenses made of the formulation of Example 1 above were cast-molded from polypropylene molds. Under an inert nitrogen atmosphere, 45- ⁇ l of the formulation was injected onto a clean polypropylene concave mold half and covered with the complementary polypropylene convex mold half. The mold halves were compressed at a pressure of 70 psi and the mixture was cured for about 15 minutes in the presence of UV light (6-11 mW/cm 2 as measured by a Spectronic UV meter). The mold was exposed to UV light for about 5 additional minutes.
  • the top mold half was removed, and the lenses were maintained at 60°C for 3 hours in a forced air oven to remove n-nonanol. Subsequently, the lens edges were ball buffed for 10 seconds at 2300 rpm with a force of 60 g.
  • EXAMPLE 3 This example illustrates the synthesis of the hydrophilic reactive copolymer involving a 80/20 by weight percent ratio of monomers (DMA/VDMO) employing the ingredients in Table 2 below:
  • VAZO-64 All ingredients except VAZO-64 were placed in a 500-ml round-bottom flask equipped with a magnetic stirrer, condenser, argon blanket, and thermo-controller. The above was de-aerated with argon for 30 min. After VAZO-64 was added, the solution was heated to 60°C and maintained for 50 hrs. After the reaction was complete as monitored by FTIR (Fourier Transform Infrared spectroscopy), the solution was slowly added to 2500 ml of diethyl ether to precipitate the polymer. The mixture was stirred 10 min, allowed to settle 10 min, and filtered.
  • FTIR Fastier Transform Infrared spectroscopy
  • Reagents DMA 200 g, 2.0 moles
  • mercaptoethanol 3.2 g, 0.041 moles
  • AJJ3N Vazo-64 in the amount 3.3 g, 0.02 moles
  • tefrahychofuran 1,000 ml
  • Nitrogen gas was bubbled through the solution for one half-hour.
  • the temperature was increased to 60°C for 72 hours under a passive blanket of nitrogen.
  • the polymer was precipitated from the reaction mixture with 20 liters of ethyl ether (171.4 g of polymer was isolated).
  • EXAMPLE 5 This Example illustrates the synthesis of a macromer of DMA using the prepolymer of Example 4 which macromonomer is used to make the hydrophilic reactive polymer of Examples 6 and 8 below, which macromonomer is made according to the following reaction scheme:
  • EXAMPLE 6 This Example illustrates the preparation of a DMA DMA-mac/NDMO polymer which may be used to form a coating according to the present invention.
  • DMA dimethylacrylamide
  • VDMO vinyl-4,4-dimethyl-2- oxazolin-5-one
  • DMA-mac dimethylacrylamide macromer
  • the solution was de-aerated with argon for 30 min. Then 0.029 g (0J mole%) of VAZO-64 was added and the reaction heated to 60°C for 50 hrs. After the reaction was complete (monitored by FT1R), the solution was slowly added to 2500 ml of ethyl ether to precipitate the polymer. After the addition was complete, the mixture was stirred 10 min, allowed to settle 10 min, and filtered. The precipitate was dried under house vacuum at 30 to 35 °C overnight. The dried polymer was sampled for analysis by gel permeation chromatography, bottled and stored in a desiccator.
  • EXAMPLE 7 This Example illustrates the preparation of a DMA/PEOMA/VDMO polymer usable to coat a silicone substrate according to the present invention.
  • Dimethylacrylamide in the amount of 12 g (0J211 mole), vinyl-4,4-dimethyl-2- oxazolin-5-one in the amount of 4 g (0.0288 mole), and 4 g (0.0036 mole) PEO methacrylate (PEOMA), which monomer has a MW of 1000, and 200 ml of toluene were placed in a 500 ml round-bottom flask equipped with a magnetic stirrer, condenser, argon blanket, and temperature controller. The solution was de-aerated with argon for 30 min.
  • PEOMA PEO methacrylate
  • the polymer consisted of the combination of the DMA macromonomer, glycidyl methacrylate, and DMA monomer, prepared as follows. To a reaction flask were added distilled N,N-dimethylacrylamide (DMA, 32g, 0.32 moles), DMA macromer from Example 5 in the amount of 4 g (0.0008 moles), distilled glycidyl methacrylate (GM, 4J g, 0.029 moles), Vazo-64 (ATBN, 0.06 g, 0.00037 moles) and toluene (500 ml). The reaction vessel was fitted with a magnetic stirrer, condenser, thermal controller, and a nitrogen inlet.
  • DMA N,N-dimethylacrylamide
  • GM glycidyl methacrylate
  • Vazo-64 ATBN, 0.06 g, 0.00037 moles
  • EXAMPLE 9 This example illustrates the synthesis of a vinylpyrrrolidone-co-4- vinylcyclohexyl-l,2-epoxide polymer (NVP-co-VCH) useful to coat a silicone substrate according to the present invention.
  • the polymer was prepared based on the following reaction scheme:
  • N-vinylpyrrolidone N-vinylpyrrolidone
  • VCHE 4-vinylcyclohexyl-l,2-epoxide
  • AIBN 0.05 g, 0.0003 moles
  • THF 600 ml
  • the reaction vessel was fitted with a magnetic stirrer, condenser, thermal controller, and a nitrogen inlet. Nitrogen was bubbled through the solution for 15 min to remove any dissolved oxygen. The reaction flask was then heated to 60°C under a passive blanket of nitrogen for 20 hrs.
  • reaction mixture was then added slowly to 6 liters of ethyl ether with good mechanical stirring.
  • the copolymer precipitated and was collected by vacuum filtration.
  • the solid was placed in a vacuum oven at 30°C overnight to remove the ether, leaving 21 g of reactive polymer (32% yield).
  • the hydrophilic reactive polymer was placed in a desiccator for storage until use.
  • the reactive polymer precipitated and was collected by vacuum filtration.
  • the solid was placed in a vacuum oven at 30°C overnight to remove the ether leaving 50J g of reactive polymer (83% yield).
  • the reactive polymer was placed in a desiccator for storage until use.
  • the reaction flask was then heated to 60° C under a passive blanket of nitrogen for 20 hours.
  • the reaction mixture was then added slowly to 3 liters of ethyl ether with good mechanical stirring.
  • the reactive polymer precipitated and was collected by vacuum filtration.
  • the solid was placed in a vacuum oven at 30°C overnight to remove the ether leaving 19.3 g of reactive polymer (92% yield).
  • the reactive polymer was placed in a desiccator for storage until use.
  • This Example illustrates the surface treatment of Balafilcon A contact lenses (Pure Vision ® lenses, commercially available from Bausch & Lomb, Inc., Rochester, NY) made from the material of Example 1, which surface treatment employed the hydrophilic reactive polymers made from Example 10 above, according to the following reaction scheme:
  • Example 14 This Example illustrates the surface treatment of an RGP Lens Surface according to the present invention, as shown below.
  • the material was Boston ® XO (hexafocon A) lens, commercially available from Bausch & Lomb, Inc.
  • the reaction scheme is given in figure I above.
  • Two polymer solutions were prepared as follows; Solution A was prepared by combining 3 grams of the reactive polymer and 1.3 grams of methyldiemanolamine with 65 ml of purified water.
  • Solution B was prepared by combining 1.6 grams of the reactive polymer and 1.3 grams of methyldiethanolamine with 65 ml of purified water.
  • RGP lenses were first cleaned with Boston Advance® and then placed in 5 ml of polymer solution. Half the samples were left standing over night and half were placed in an oven at 55°C for one hour. All treated samples were rinsed twice with HPLC grade water and allowed to dry.
  • a Physical Electronics [PHI] Model 5600 XPS was used for the surface characterization.
  • This instrument utilized a monochromated Al anode operated a 300 watts, 15kV and 20 milliamps.
  • the base pressure of the instrument was 2.0 x 10 "10 torr and during operation the pressure was 5.0 x 10 "8 torr.
  • This instrument made use of a hemispherical analyzer.
  • the instrument had an Apollo workstation with PHI 8503A version 4.0A software.
  • the practical measure for sampling depth for this instrument at a sampling angle of 45° was 74A.
  • Each specimen was analyzed utilizing a low-resolution survey spectra (0- HOOeV) to identify the elements present on the sample surface (10-lO ⁇ A).
  • Surface elemental compositions were determined from high-resolution spectra obtained on the elements detected in the low-resolution survey scans. Those elements included oxygen, nitrogen, carbon, silicon and fluorine. Quantification of elemental compositions was completed by integration of the photoelectron peak areas after sensitizing those areas with the instrumental transmission function and atomic cross sections for the orbitals of interest.
  • the fluorine ratio was calculated as follows; [F] con ⁇ HF] test ⁇ [F] C0ntI0l .
  • the silicone ratio was calculated in a similar manner [Si] conta) ⁇ -[Si] test ⁇ [Si] Contro i- Th us these data further suggest that the substrates were nearly completely covered by the coating polymer.
  • EXAMPLE 15 This Example illustrates another surface treatment of an Boston ® XO contact lens material, commercially available from Bausch & Lomb, Inc., according to the following reaction sequence:
  • the material substrate for this experiment was the Boston XO® lens.
  • the reaction scheme is shown above in Example 15. Two solutions of reactive polymers were prepared. The first was a solution of DMA 86moIe% -co-GMA 14mole% (3 g /60 ml of water). The second solution was prepared by mixing DMA 76mole% -co-MAA 24mole% (3 g / 60 ml of water) and methyldiethanolamine (2.5 g/ 60 ml of water). The two solutions were passed through a Millipore 5 -micron type LS membrane filter and then combined to give a mixed solution of 5% polymer by weight. Boston XO® lenses were then placed in the 5 ml of reactive polymer mixture and allowed to stand for 4, 8 and 16 hours. The lenses were then rinsed off twice with purified water and submitted for XPS and TOF- SDVIS analyses.
  • the XPS data is given below.
  • a solution was prepared, of reactive polymer, N,N-dimethylacrylamide-co-glycidyl methacrylate (0.4 g/ 20 ml of HPLC water) and eight drops of triethanolamine.
  • Polished buttons (4 samples) were imaged by non-contact atomic force microscopy then cleaned by rubbing with HPLC grade water.
  • the substrates were then placed in the 4-5 ml of reactive polymer solution, in sealed lens flat packs and heated to 55°C for one hour.
  • the treated polymer buttons were then rinsed off twice with HPLC water and allowed to dry. A drop of water placed on an untreated lens would bead up and roll off the surface while a drop of water was placed on the treated lens spread completely wetting the lens surface.
  • buttons were then cleaned with 3-4 drops of Boston ® Advance brand contact lens cleaner, a sterile surfactant solution containing silica gel as an abrasive-cleaning agent, followed by rinsing (2 times with) HPLC grade water.
  • the polymer buttons were allowed to dry and AFM images were again recorded. The images appeared to be equivalent to those taken before any coating was applied.
  • Example 18 The procedure of this Example 18 was repeated with three fresh RGP contact lens material buttons.
  • Surface analysis for the repeated experiment was x-ray photoelectron spectroscopy (XPS).
  • XPS x-ray photoelectron spectroscopy
  • the XPS data is given in the table below. It is clearly evident from the data given below, looking at the increase of nitrogen (N, from the coating polymer) and the corresponding decreases of silicon (Si) and fluorine (F) in the substrate, that the polymer coating was applied, removed and applied again.
  • Figure 7 is an AFM topographical image (50 ⁇ m 2 ) of an RGP contact lens material button of Example 18 prior to surface treatment.
  • Figure 8 is an AFM topographical image (50 ⁇ m 2 ) of the surface of an RGP button after a first hydrophilic polymer coating step in Example 18.
  • Figure 9 is an AFM topographical image (50 ⁇ m 2 ) of the surface of an RGP button after abrasive removal of the polymer coating in Example 18.
  • Figure 10 is an AFM topographical image (50 ⁇ m 2 ) of the surface of an RGP button after the hydrophilic polymeric surface was re-applied in Example 18.
  • the ether solution was washed with purified water, dried over magnesium sulfate and again flash evaporated leaving 98.5 grams of crude product.
  • the crude product was further purified by silica gel chromatography using a 1:2 mixture of ethylacetate and heptane to give a 63 % yield.
  • Example 20 illustrates the synthesis of a hydrophilic reactive polymer of N,N- dimethylacrylamide -co- 12-methacryloyloxydodecanoic acid.
  • EXAMPLE 21 illustrates the synthesis of a hydrophilic reactive polymer of N,N- dimethylacrylamide -co- 12-methacryloyloxydodecanoic acid.
  • This Example illustrates the synthesis of a hydrophilic reactive polymer of N,N- dimethylacrylamide -co-octafluoropentyl methacrylate-co- 12- methacryloyloxydodecanoic acid.
  • reaction vessel was fitted with a magnetic stirrer, condenser, thermal controller and a nitrogen inlet. Nitrogen was bubbled through the solution for 15 minutes to remove any dissolved oxygen. The reaction flask was then heated to 60° C under a passive blanket of nitrogen for 72 hours. The reaction mixture was then added slowly to 2.5L of heptane with good mechanical stirring. The reactive polymer precipitated and was collected by vacuum filtration. The solid was placed in a vacuum oven at 30°C overnight to remove the ether leaving 18.7g of reactive polymer (94 % yield). The reactive polymer was placed in a desiccator for storage until use.
  • Example 22 illustrates the synthesis of a hydrophilic reactive polymer of N,N- dimethylacrylamide -co-laurylmethacrylate-co-glycidyl methacrylate.

Abstract

The present invention is directed toward the renewable surface treatment of medical devices such as contact lenses and medical implants. In particular, the present invention is directed to a method of modifying the surface of a medical device to increase its biocompatibility or hydrophilicity by coating the device with a removable hydrophilic polymer by means of reaction between reactive functionalities on the hydrophilic polymer which functionalities are complementary to reactive functionalities on or near the surface of the medical device at reaction temperatures of less than about 55 °c.

Description

METHOD FOR APPLYING POLYMERIC LENS COATING
Cross-Reference to Related Applications
This application is related by subject matter to commonly-assigned US Application Serial No. 09/315,620, filed May 20, 1999, and Application Serial No. 09/541,588, filed April 3, 2000.
FIELD OF THE INVENTION The present invention is directed toward the surface treatment of medical devices such as contact lenses and medical implants. In particular, the present invention is directed to a method of renewably modifying the surface of a medical device to increase its biocompatibility or hydrophilicity by coating the device with a hydrophilic polymer by reaction between reactive functionalities in the contact lens material and complementary reactive functionalities on the hydrophilic polymer. The present invention is also directed to a contact lens or other medical device having such a surface coating.
BACKGROUND
Contact lenses made from silicone-containing materials have been investigated for a number of years. Such materials can generally be subdivided into two major classes: hydrogels and non-hydrogels. Non-hydrogels do not absorb appreciable amounts of water, whereas hydrogels can absorb and retain water in an equilibrium state. Hydrogels generally have a water content greater than about five weight percent and more commonly between about 10 to about 80 weight percent. Regardless of their water content, both non-hydrogel and hydrogel silicone contact lenses tend to have relatively hydrophobic, non-wettable surfaces.
Surface structure and composition determine many of the physical properties and ultimate uses of solid materials. Characteristics such as wetting, friction, and adhesion or lubricity are largely influenced by surface characteristics. The alteration of surface characteristics is of special significance in biotechnical applications, where biocompatibility is of particular concern. Therefore, those skilled in the art have long recognized the need for rendering the surface of contact lenses and other medical devices hydrophilic or more hydrophttic. Increasing the hydrophilicity of the contact-lens surface improves the wettability of the contact lenses with tear fluid in the eye. This in turn improves the wear comfort of the contact lenses. In the case of continuous-wear lenses, the surface is especially important. The surface of a continuous-wear lens must be designed not only for comfort, but to avoid adverse reactions such as corneal edema, inflammation, or lymphocyte infiltration. Improved methods have accordingly been sought for modifying the surfaces of contact lenses, particularly high-Dk (highly oxygen permeable) lenses designed for continuous (overnight) wear.
Various patents disclose the attachment of hydrophilic or otherwise biocompatible polymeric chains to the surface of a contact lens in order to render the lens more biocompatible. For example, U.S. Patent No. 5,652,014 teaches amination of a substrate followed by reaction with other polymers, such as a PEO star. molecule or a sulfated polysaccharide. One problem with such an approach is that the polymer chain density is limited due to the difficult of attaching the polymer to the silicone substrate.
U.S. Patent 5,344,701 discloses the attachment of oxazolinone or azlactone monomers to a substrate by means of plasma. The invention has utility in the field of surface-mediated or catalyzed reactions for synthesis or site-specific separations, including affinity separation of biomolecules, diagnostic supports and enzyme membrane reactors. The oxazolinone group is attached to a porous substrate apparently by reaction of the ethylenic unsaturation in the oxazolinone monomer with radicals formed by plasma on the substrate surface. Alternatively, the substrate can be coated with monomers and reacted with plasma to form a cross-linked coating. The oxazolinone groups that have been attached to the surface can then be used to attach a biologically active material, for example, proteins, since the oxazolinone is attacked by amines, thiols, and alcohols. U.S. Patent No. 5,364,918 to Valint et al. and U.S. Patent No. 5,352,714 to Lai et al. disclose the use of oxazolinone monomers as internal wetting agents for contact lenses, which agents may migrate to the surface of the contact lens.
US Patent No. 5,804,318 to Pinchuk et al. discloses lubrifying coatings for reducing the coefficients of friction of surfaces on medical devices, including hydrophilic copolymers containing some monomers having pendant tertiary amine functionality. The hydrogel coatings are covalently bondable to epoxy functionalized surfaces on the medical equipment.
US Patent No. 4,734,475 to Goldenberg et al. discloses the use of a contact lens fabricated from a polymer comprising oxirane (epoxy) substituted monomeric units in the backbone, such that the outer surfaces of the lens contain a hydrophilic inducing amount of the reaction product of the oxirane monomeric units with a water soluble reactive organic, amine, alcohol, thiol, urea, thiourea, sulfite, bisulfite or thiosulfate.
In view of the above, it would be desirable to find an optically clear, hydrophilic coating for the surface of a silicone medical device that renders the device more biocompatible. It would also be desirable to form a coating for a silicone hydrogel contact lens that is more comfortable for a longer period of time, simultaneously tear- wettable and highly permeable to oxygen. It would be desirable if such a biocompatibilized lens was capable of continuous wear overnight, preferably for a week or more without adverse effects to the cornea. Further, it would be desirable to provide a coating with these properties that can be readily renewed to restore its properties to an as-new state.
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 shows an Atomic Force Microscopy (AFM) topographical image (50 μm2) of a control contact lens described in Example 15 below, for comparison to a contact lenses according to the invention; the image of the anterior side of the lens is shown on the left of FIG. 1 and the image of the posterior side is shown on the right.
FIG. 2 shows an Atomic Force Microscopy (AFM) topographical image (50 μm2) of a contact lens coated described in Example 14 according to one embodiment of the present invention, which lens is a silicone rigid-gas-permeable lens coated with a polymer as described in Example 10, a copolymer of dimethyl acrylamide and glycidyl methacrylate.
FIG. 3 shows an Atomic Force Microscopy (AFM) topographical image (50 μm2) of a contact lens coated described in Example 15 according to one embodiment of the present invention, which lens is a silicone rigid-gas-permeable lens coated with a combination of the hydrophilic copolymers described in Examples 10 and Example 12.
FIG. 4 shows Atomic Force Microscopy (AFM) topographical image (50 μm2) of a control contact lens described in Example 16 for comparison to other lenses according to another embodiment of the present invention, which lens is a silicone hydrogel lens coated with a polymer as described in Example 11.
FIG. 5 shows Atomic Force Microscopy (AFM) topographical image (50 μm2) of a contact lens coated described in Example 16 according to one embodiment of the present invention, which lens is a silicone hydrogel lens coated with a polymer as described in Example 11, a copolymer of dimethyl acrylamide, glycidyl methacrylate, and octafluoropentylmethacrylate.
FIG. 6 shows Atomic Force Microscopy (AFM) topographical image (50 μm2) of a contact lens coated described in Example 16 according to one embodiment of the present invention, which lens is a silicone hydrogel lens coated with a polymer as described in Example 11, a copolymer of dimethyl acrylamide, glycidyl methacrylate, and octafluoropentylmethacrylate, which is used for coating at a higher concentration than was used for coating the lens in FIG. 5.
FIG. 7 is an Atomic Force Microscopy (AFM) topographical image (50 μm2) of an RGP contact lens material button of Example 18 prior to surface treatment.
FIG. 8 is an Atomic Force Microscopy (AFM) topographical image (50 μm2) of the surface of an RGP button after a first hydrophilic polymer coating step in Example 18.
FIG. 9 is an Atomic Force Microscopy (AFM) topographical image (50 μm2) of the surface of an RGP button after abrasive removal of the polymer coating in Example 18. FIGJO is an Atomic Force Microscopy (AFM) topographical image (50 μm2) of the surface of an RGP button after the hydrophilic polymeric surface was reapplied in Example 18.
SUMMARY OF THE INVENTION
The present invention is directed toward surface treatment of silicone contact lenses and other silicone medical devices, including a method of modifying the surface of a contact lens to increase its hydrophilicity or wettability. The surface treatment comprises the attachment of hydrophilic polymer chains at reaction temperatures of less than 55°c to the surface of the contact lens substrate by means of reactive functionalities in the lens substrate material reacting with complementary reactive functionalities in monomeric units along a hydrophilic reactive polymer. Subsequently the hydrophiUc polymer chains can be removed from the contact lens substrate and then re-applied to achieve substantially as-new surface quality. As used here, the term "as-new surface quality" means a re-applied surface resembling the original surface coating in appearance and material properties. In a preferred embodiment, the reaction temperature is from 15 to about 45 °c, more preferably from about 20 to about 40°c, most preferably about ambient temperature.
The present invention is also directed to a medical device, examples of which include contact lenses, intraocular lenses, catheters, implants, and the like, comprising a surface made by such a method.
Examples of medical devices that can be fabricated in accordance with the present invention include dental appliances, including retainers and mouth guards, hearing aids, yarns for clothing or for orthopaedic or other medical/surgical implants and appliances such as punctal plugs, stents and braces.
DETAILED DESCRIPTION OF THE INVENTION As stated above, the present invention is directed toward surface treatment of medical devices, including contact lenses, intraocular lenses and vascular implants, to improve their biocompatibility. The present invention is especially advantageous for application to contact lenses, such as hydrogels, silicone hydrogels, and rigid-gas- permeable lens materials. The invention is especially advantageous for silicone rigid- gas-permeable lenses. Both rigid-gas-permeable ("RGP") materials and hydrogels are well-known classes of materials. By the term silicone, it is meant that the material being treated is an organic polymer comprising at least five percent by weight silicone (-OSi- linkages), preferably 10 to 100 percent by weight silicone, more preferably 30 to 90 percent by weight silicone.
RGP materials typically comprise a hydrophobic cross-linked polymer system containing less than 5 wt. % water. RGP materials useful in accordance with the present invention include those materials taught in US Patent No. 4,826,936 to Ellis; 4,463,149 to Ellis; 4,604,479 to Ellis; 4,686,267 to Ellis et al.; 4,826,936 to Ellis; 4,996,275 to Ellis et al.; 5,032,658 to Baron et al.; 5,070,215 to Bambury et al.; 5,177,165 to Valint et al.; 5,177,168 to Baron et al.; 5,219,965 to Valint et al.; 5,336,797 to McGee and Valint; 5,358,995 to Lai et al.; 5,364,918 to Valint et al.; 5,610,252 to Bambury et al.; 5,708,094 to Lai et al; and 5,981,669 to Valint et al. US Patent 5,346,976 to Ellis et al. teaches a preferred method of making an RGP material.
Hydrogels comprise hydrated, cross-linked polymeric systems containing water in an equilibrium state. Silicone hydrogels generally have a water content greater than about five weight percent and more commonly between about ten to about eighty weight percent. Such materials are usually prepared by polymerizing a mixture containing at least one silicone-containing monomer and at least one hydrophilic monomer. Either the silicone-containing monomer or the hydrophilic monomer may function as a cross- linking agent (a cross-linker being defined as a monomer having multiple polymerizable functionalities) or a separate cross-linker may be employed. Applicable silicone- containing monomeric units for use in the formation of silicone hydrogels are well known in the art and numerous examples are provided in U.S. Patent Nos. 4,136,250; 4,153,641; 4,740,533; 5,034,461; 5,070,215; 5,260,000; 5,310,779; and 5,358,995.
Examples of applicable silicon-containing monomeric units include bulky polysiloxanylalkyl (meth)acrylic monomers. An example of bulky polysiloxanylalkyl (meth)acrylic monomers is represented by the following Formula I:
Figure imgf000009_0001
wherein:
X denotes -O- or -NR-; each R18 independently denotes hydrogen or methyl; each R19 independently denotes a lower alkyl radical, phenyl radical or a group represented by
Figure imgf000009_0002
wherein each R19. independently denotes a lower alkyl or phenyl radical; and h is 1 to 10.
Some preferred bulky monomers are methacryloxypropyl tris(trimethyl- siloxy)silane or tris(trimethylsiloxy)silylpropyl methacrylate, sometimes referred to as TRIS and tris(trimethylsiloxy)silylpropyl vinyl carbamate, sometimes referred to as TRIS-VC.
Such bulky monomers may be copolymerized with a silicone macromonomer, which is a poly(organosiloxane) capped with an unsaturated group at two or more ends of the molecule. U.S. Patent No. 4,153,641 to Deichert et al. discloses, for example, various unsaturated groups, including acryloxy or methacryloxy.
Another class of representative silicone-containing monomers includes silicone- containing vinyl carbonate or vinyl carbamate monomers such as: l,3-bis[4- vinyloxycarbonyloxy)but-l-yl]tetramethyl-disiloxane; 3-(trimethylsilyl)propyl vinyl carbonate; 3-(vinyloxycarbonylthio)propyl-[tris(trimethylsiloxy)silane]; 3-[tris(tri- methylsiloxy)silyl] propyl vinyl carbamate; 3-[tris(trimethylsiloxy)silyl] propyl allyl carbamate; 3-[tris(trimethylsiloxy)silyl]propyl vinyl carbonate; t- butyldimethylsiloxyethyl vinyl carbonate; trimethylsilylethyl vinyl carbonate; and trimethylsilylmethyl vinyl carbonate.
Another class of silicon-containing monomers includes polyurethane- polysiloxane macromonomers (also sometimes referred to as prepolymers), that may have hard-soft-hard blocks like traditional urethane elastomers. Examples of silicone urethanes are disclosed in a variety or publications, including Lai, Yu-Chin, "The Role of Bulky Polysiloxanylalkyl Methacryates in Polyurethane-Polysiloxane Hydrogels, " Journal of Applied Polymer Science, Vol. 60, 1193-1199 (1996). PCT Published Application No. WO 96/31792 and US Patents No. 5,451,617 and 5,451,651 disclose examples of such monomers, which disclosures are hereby incorporated by reference in their entirety. Further examples of silicone urethane monomers are represented by Formulae π and DI:
(D) E(*D*A*D*G)a*D*A*D*E'; or
(DT) E(*D*G*D*A)a*D*G*D*E';
wherein:
D denotes an alkyl diradical, an alkyl cycloalkyl diradical, a cycloalkyl diradical, an aryl diradical or an alkylaryl diradical having 6 to 30 carbon atoms;
G denotes an alkyl diradical, a cycloalkyl diradical, an alkyl cycloalkyl diradical, an aryl diradical or an alkylaryl diradical having 1 to 40 carbon atoms and which may contain ether, thio or amine linkages in the main chain;
* denotes a urethane or ureido linkage; a is at least 1;
A denotes a divalent polymeric radical of Formula IN: <
(IN)
Figure imgf000011_0001
wherein: each Rs independently denotes an alkyl or fluoro-substituted alkyl group having 1 to 10 carbon atoms which may contain ether linkages between carbon atoms; m' is at least 1; and p is a number that provides a moiety weight of 400 to 10,000; each of E and E' independently denotes a polymerizable unsaturated organic radical represented by Formula VI:
(NI)
Figure imgf000011_0002
wherein:
R23 is hydrogen or methyl;
R24 is hydrogen, an alkyl radical having 1 to 6 carbon atoms, or a -CO-Y-R26 radical wherein Y is -O-, -S- or -ΝH-;
R25 is a divalent alkylene radical having 1 to 10 carbon atoms;
R26 is a alkyl radical having 1 to 12 carbon atoms;
X denotes -CO- or -OCO-;
Z denotes -O- or -NH-;
Ar denotes an aromatic radical having 6 to 30 carbon atoms; w is 0 to 6; x is 0 or 1; y is 0 or 1; and z is 0 or 1.
A preferred silicone-containing urethane monomer is represented by Formula
(VTJ): (VD)
Figure imgf000012_0001
wherein m is at least 1 and is preferably 3 or 4, a is at least 1 and preferably is 1, p is a number which provides a moiety weight of 400 to 10,000 and is preferably at least 30, R27 is a diradical of a diisocyanate after removal of the isocyanate group, such as the diradical of isophorone diisocyanate, and each E" is a group represented by:
Figure imgf000012_0002
Another class of representative silicone-containing monomers includes fluorinated monomers. Such monomers have been used in the formation of fluorosilicone hydrogels to reduce the accumulation of deposits on contact lenses made therefrom, as described in U.S. Patent Nos. 4,954,587, 5,079,319 and 5,010,141. The use of silicone-containing monomers having certain fluorinated side groups, i.e. -(CF2)-H, have been found to improve compatibility between the hydrophilic and silicone- containing monomeric units, as described in U.S. Patent Nos. 5,387,662 and 5,321,108.
In one preferred embodiment of the invention, a silicone hydrogel material comprises (in bulk, that is, in the monomer mixture that is copolymerized) 5 to 50 percent, preferably 10 to 25, by weight of one or more silicone macromonomers, 5 to 75 percent, preferably 30 to 60 percent, by weight of one or more polysiloxanylalkyl (meth)acrylic monomers, and 10 to 50 percent, preferably 20 to 40 percent, by weight of a hydrophilic monomer. Examples of hydrophilic monomers include, but are not limited to, ethylenically unsaturated lactam-containing monomers such as N-vinyl pyrrolidinone, methacrylic and acrylic acids; acrylic substituted alcohols, such as 2- hydroxyethylmethacrylate and 2-hydroxyethylacrylate and acrylamides, such as methacrylamide and N,N-dimethylacrylamide, vinyl carbonate or vinyl carbamate monomers such as disclosed in U.S. Patent Nos. 5,070,215, and oxazolinone monomers such as disclosed in U.S. Patent No. 4,910,277. Other hydrophilic monomers such as N,N-dimethyl acrylamide (DMA), 2-hydroxyethyl methacrylate (HEMA), glycerol methacrylate, 2-hydroxyethyl methacrylamide, polyethyleneglycol, monomethacrylate, methacrylic acid and acrylic acid are also useful in the present invention. Other suitable hydrophilic monomers will be apparent to one skilled in the art.
The above silicone materials are merely exemplary, and other materials for use as substrates that can benefit by being coated according to the present invention have been disclosed in various publications and are being continuously developed for use in contact lenses and other medical devices.
As indicated above, the present invention is directed to the modification of the surface of a medical device such as a contact lens by means of removably attaching to the surface hydrophilic polymer chains. The term "removably attaching" refers to creating a chemical bond between the substrate material and the hydrophilic polymer chains which can be severed without substantial mechanical damage to the substrate
The hydrophilic polymer chains of the invention can be chemically or mechanically removed from the substrate material, for example by abrasion. Suitable mechanical means include high shear fluidic treatments such as a high speed fluid jet, as well as contacting the surface with a fluidized abrasive solid. The hydrophilic polymeric surface coating may also be mechanically removed by grinding or polishing.
The preferred mechanical method for removing the polymeric surface coating of the invention from contact lenses is rubbing the contact lens with a commercially available abrasive cleaner containing an abrasive such as silica or aluminum oxide together with one or more of an anionic surfactant (such as an alkyl ether sulfonate), a nonionic surfactant (such as an ethoxylated alkyl phenol) and a cationic surfactant (such as a quaternary ammonium salt). Particularly preferred abrasive cleaners include Boston® and Boston Advanced® brand abrasive cleaners, commercially available from Bausch & Lomb, Rochester, NY, 14604.
Suitable chemical means for removing the hydrophilic polymeric surface coating include oxidation, for example oxidative plasma, ozonation or corona discharge. Other chemical means include chemical hydrolysis, hydrolytic cleavage or enzymatic removal.
The hydrophihc polymer chains are attached to the surface by means of exposing the surface to hydrophihc reactive polymers (inclusive of oligomers) having ring- opening or isocyanate reactive functionalities complementary to reactive groups on the surface of the medical device. Alternatively, the hydrophihc polymer chains may be attached to the surface by means of exposing the surface to hydrophilic reactive polymers (inclusive of oligomers) having hydroxy or (primary or secondary) amine groups complementary to azlactone reactive groups in the silicone material or having carboxylic acid complementary groups complementary to epoxy reactive groups in the silicone material. In other words, chemical functionality at the surface of the medical device is utilized to covalently attach hydrophilic polymers to the object or substrate.
The hydrophihc reactive polymers may be homopolymers or copolymers comprising reactive monomeric units that contain either an isocyanate or a ring-opening reactive functionality optionally. Although these reactive monomeric units may also be hydrophilic, the hydrophilic reactive polymer may also be a copolymer of reactive monomeric units copolymerized with one or more of various non-reactive hydrophilic monomeric units. Lesser amounts of hydrophobic monomeric units may optionally be present in the hydrophilic polymer. The ring-opening monomers include azlactone- functional, epoxy-functional and acid-anhydride-functional monomers.
Mixtures of hydrophilic reactive polymers may be employed. For example, the hydrophilic polymer chains attached to the substrate may be the result of the reaction of a mixture of polymers comprising (a) a first hydrophilic reactive polymer having reactive functionalities in monomeric units along the hydrophihc polymers complementary to reactive functionalities on the substrate surface and, in addition, (b) a second hydrophihc reactive polymer having supplemental reactive functionalities that are reactive with the first hydrophilic reactive polymer. A mixture comprising an epoxy-functional polymer with an acid-functional polymer, either simultaneously or sequentially applied to the substrate to be coated, have been found to provide relatively thick coatings. Utilizing a mixture of reactive polymers provides a means to further adjust the surface chemistry of a substrate material.
Preferably the hydrophilic reactive polymers comprise 1 to 100 mole percent of reactive monomeric units, more preferably 5 to 50 mole percent, most preferably 10 to40 mole percent. The polymers may comprise 0 to 99 mole percent of non-reactive hydrophilic monomeric units, preferably 50 to 95 mole percent, more preferably 60 to 90 mole percent (the reactive monomers, once reacted may also be hydrophilic, but are by definition mutually exclusive with the monomers referred to as hydrophilic monomers which are non-reactive). The weight average molecular weight of the hydrophihc reactive polymer may suitably range from about 200 to 1,000,000, preferably from about 1,000 to 500,000, most preferably from about 5,000 to 100,000.
Hydrophilic monomers may be aprotic types such as acrylamides (N,N- dimethylacrylamide, DMA), lactams such as N-vinylpyrrolidinone, and poly(alkylene oxides) such as methoxypolyoxyethylene methacrylates or may be protic types such as methacrylic acid or hydroxyalkyl (meth)acrylates such as hydroxyethyl (meth)acrylate. Hydrophilic monomers may also include anionic surfactants such as sodium acrylamido- 2-methylpropylsulfonate (AMPS) and zwitterions such as N,N-dimethyl-N- memacryloxyemyl-N-(3-sulfopropyl)-ammonium betain (SPE) and N,N-dimethyl-N- memacrylamidopropyl-N-(3-sulfopropyl)-ammonium betain (SPP).
Monomeric units which are hydrophobic optionally may be used in amounts up to 35 mole percent, preferably 0 to 20 mole percent, most preferably 0 to 10 mole percent. Examples of hydrophobic monomers are alkyl methacrylate, fluorinated alkyl methacrylates, long-chain acrylamides such as octyl acrylamide, and the like.
As mentioned above, the hydrophilic reactive polymer may comprise reactive monomeric units derived from azlactone-functional, epoxy-functional and acid- anhydride-functional monomers. For example, an epoxy-functional hydrophilic reactive polymer for coating a lens can be a copolymer contaimng glycidyl methacrylate (GMA) monomeric units, which will react, for example, with a lens substrate comprising carboxylic acid groups. Preferred examples of anhydride-functional hydrophilic reactive polymers comprise monomeric units derived from monomers such as maleic anhydride and itaconic anhydride.
In general, epoxy-functional reactive groups or arihyc de-functional reactive groups in the hydrophilic reactive polymer react with carboxylic (-COOH), alcohol (-OH), primary amine (-NH2) groups or thiol groups (-SH) in the substrate, for example, substrates made from polymers comprising as monomeric umts from methacrylic acid (MAA), hydroxyalkylmethacrylates such as hydroxyethylmethacrylate (HEMA), or aminoalkyl methacrylates such as aminopropylmethacrylate, all common and commercially available monomers. In the case of alcohols, a catalyst such as 4- dime ylaminopyridine may be used to speed the reaction at room temperature, as will be understood by the skilled chemist. Acidic groups may also be created in the substrate by the use of azlactone monomeric units that are hydrolyzed to the acid. These acid groups can be reacted with an epoxy or anhydride group in the hydrophilic reactive polymer. See, for example, US Patent No. 5,364,918 to Valint et al., herein incorporated by reference in its entirety, for examples of such substrates.
In general, azlactone or isocyanate-functional groups in the hydrophilic reactive polymers may similarly react with amines or alcohols in the polymer substrate, reactions involving an alcohol preferably in the presence of a catalyst. In addition, carboxylic acids, amines and hydrolyzed azlactones in the hydrophilic reactive polymers may react with epoxy-groups in the substrate, for example, the monomeric units described in US Patent No. 4,734,475 to Goldenberg et al., herein incorporated by reference in its entirety.
In a preferred embodiment of the invention, preformed (non-polymerizable) hydrophilic polymers containing repeat units derived from at least one ring-opening monomer, an isocyanate-containing monomer, an amine-containing monomer, a hydroxy-containing monomer, or a carboxylic containing monomer are reacted with reactive groups on the surface of the medical device such as a contact lens substrate. Typically, the hydrophilic reactive polymers are attached to the substrate at one or more places along the chain of the polymer. After attachment, any unreacted reactive functionalities in the hydrophilic reactive polymer may be hydrolyzed to a non-reactive moiety, hi the case of epoxy, isocyanate or ring-opening monomeric units.
Suitable hydrophilic non-reactive monomers for comprising the hydrophilic reactive polymers include generally water soluble conventional vinyl monomers such as 2-hydroxyethyl-; 2- and 3-hydroxypropyl-; 2,3-dihydroxypropyl-; polyethoxyethyl-; and polyethoxypropylacrylates, methacrylates, acrylamides and methacrylamides; acrylamide, methacrylamide, N-methylacrylamide, N-methylmemacrylamide, N, N- dimethylacrylamide, N, N-dimethylmethacrylamide, N, N- dimethyl- and N, N-diethyl- aminoethyl acrylate and methacrylate and the corresponding acrylamides and methacrylamides; 2-and 4-vinylpyridine; 4-and 2-methyl-5-vinylpyridine; N-methyl-4- vinylpiperidine; 2-metfayl-l-vinylimidazole; N,-N-dime ylallylarnine; dimemylaminoethyl vinyl ether and N-vinylpyrrolidone.
Included among the useful non-reactive monomers are generally water soluble conventional vinyl monomers such as acrylates and methacrylates of the general structure
R-2 H2C=C— COOR3 where R2 is hydrogen or methyl and R3 is hydrogen or is an aliphatic hydrocarbon group of up to 10 carbon atoms substituted by one or more water solubilizing groups such as carboxy, hydroxy, a ino, lower alltylamino, lower dialkyamino, a polyethylene oxide group with from 2 to about 100 repeating units, or substituted by one or more sulfate, phosphate, sulfonate, phosphonate, carboxamido, sulfonamido or phosphonamido groups, or mixtures thereof; Preferably R3 is an oligomer or polymer such as polyethylene glycol, polypropylene glycol, ρoly(ethylene-propylene) glycol, poly(hydroxyethyl methacrylate), poly(dimethyl acrylamide), ρoly(acrylic acid), poly(methacrylic acid), polysulfone, poly(vinyl alcohol), polyacrylamide, poly(acrylamide-acrylic acid) poly(styrene sulfonate) sodium salt, poly(ethylene oxide), poly(ethylene oxide-propylene oxide), poly(glycolic acid), poly(lactic acid), poly(vinylpyrrolidone), cellulosics, polysaccharides, mixtures thereof, and copolymers thereof; acrylamides and methacrylamides of the formula:
H2C=C— CONHR3 R2
where R2 and R3 are as defined above; acrylamides and methacrylamides of the formula:
HjCOCONfltώ
2
where R4 is lower alkyl of 1 to 3 carbon atoms and R2 is as defined above;
itaconates of the formula:
CH2=CCH2COOR3 COOR3
where R3 is as defined above;
maleates and fumarates of the formula:
R3OOCH=CHCOOR3 wherein R3 is as defined above;
vinyl ethers of the formula H2C=CH-O-R3
where R3 is as defined above; aliphatic vinyl compounds of the formula
R2CH=CHR3
where R2 is as defined above and R3 is as defined above with the proviso that R3 is other than hydrogen; and vinyl substituted heterocycles, such as vinyl pyridines, piperidines and imidazoles and N- vinyl lactams, such as N-vinyl-2-pyrrolidone.
Included among the useful water soluble monomers are acrylic and methacrylic acid; itaconic, crotonic, fumaric and maleic acids and the lower hydroxyalkyl mono and diesters thereof, such as the 2-hydroxethyl fumarate and maleate, sodium acrylate and methacrylate; 2-methacryloyloxyethylsulfonic acid and allylsulfonic acid.
The inclusion of some hydrophobic monomers in the hydrophilic reactive polymers may provide the benefit of causing the formation of tiny dispersed polymer aggregates in solution, evidenced by a haziness in the solution of the polymer. Such aggregates can also be observed in Atomic Force Microscopy images of the coated medical device.
Suitable hydrophobic copolymerizable monomers include water insoluble conventional vinyl monomers such as acrylates and methacrylates of the general formula:
R2
H2C=C-COOR5
where R2 is as defined above and R5 is a straight chain or branched aliphatic, cycloaliphatic or aromatic group having up to 20 carbon atoms which is unsubstituted or substituted by one or more alkoxy, alkanoyloxy or alkyl of up to 12 carbon atoms, or by halo, especially chloro or preferably fluoro, C2 to C5 polyalkyleneoxy of 2 to about 100 units, or an oligomer such as polyethylene, poly(methyl methacrylate), poly(ethyl methacrylate), or poly(glycidyl methacrylate), mixtures thereof, and copolymers thereof; acrylamides and methacylamides of the general formula:
H2C=C-CONHR5
where R2 and R5 are defined above; vinyl ethers of the formula
H2C=CH-O-R5 where R^ is as defined above; vinyl esters of the formula
H2C=CH-OCO-R5
where Rj is as defined above; itaconates of the formula:
CH2=CCH2COOR5
COOR5 where Rs is as defined above; maleates and fumarates of the formula
R5OOC-HC=CH-OOOR5
where Rj is as defined above; and vinylic substituted hydrocarbons of the formula:
R2CH=CH
where R2 and Rj is as defined above
Useful or suitable hydrophobic monomers include, for example: methyl, ethyl, propyl, isopropyl, butyl, ethoxyethyl, methoxyethyl, ethoxypropyl, phenyl, benzyl, cyclohexyl, hexafluoroisopropyl, or n-octyl-acrylates and -methacrylates as well as the corresponding acrylamides and methacrylamides; dimethyl fumarate, dimethyl itaconate, dimethyl maleate, diethyl fumarate, methyl vinyl ether, ethoxyethyl vinyl ether, vinyl acetate, vinyl propionate, vinyl benzoate, acrylonitrile, styrene, alpha-methylstyrene, 1- hexene, vinyl chloride, vinyl methylketone, vinyl stearate, 2-hexene and 2-ethylhexyl methacrylate.
The hydrophihc reactive polymers are synthesized in a manner known per se from the corresponding monomers (the term monomer here also including a macromer) by a polymerization reaction customary to the person skilled in the art. Typically, the hydrophihc reactive polymers or chains are formed by: (1) mixing the monomers together; (2) adding a polymerization initiator; (3) subjecting the monomer/initiator mixture to a source of ultraviolet or actinic radiation and/or elevated temperature and curing said mixture. Typical polymerization initiators include free-radical-generating polymerization initiators of the type illustrated by acetyl peroxide, lauroyl peroxide, decanoyl peroxide, coprylyl peroxide, benzoyl peroxide, tertiary butyl peroxypivalate, sodium percarbonate, tertiary butyl peroctoate, and azobis-isobutyronitrile (ATBN). Ultraviolet free-radical initiators illustrated by diethoxyacetophenone can also be used. The curing process will of course depend upon the initiator used and the physical characteristics of the comonomer mixture such as viscosity. In any event, the level of initiator employed will vary within the range of 0.001 to 2 weight percent of the mixture of monomers. Usually, a mixture of the above-mentioned monomers is warmed with addition of a free-radical former.
A polymerization to form the hydrophilic reactive polymer can be carried out in the presence or absence of a solvent. Suitable solvents are in principle all solvents which dissolve the monomer used, for example water; alcohols such as lower alkanols, for example, ethanol and methanol; carboxamides such as dimethylformamide, dipolar aprotic solvents such as dimethyl sulfoxide or methyl ethyl ketone; ketones such as acetone or cyclohexanone; hydrocarbons such as toluene; ethers such as THF, dimethoxyethane or dioxane; halogenated hydrocarbons such as trichloroethane, and also mixtures of suitable solvents, for example mixtures of water and an alcohol, for example a water/ethanol or water/methanol mixture.
In a method according to the present invention, the contact lens or other medical device may be exposed to hydrophilic reactive polymers by immersing the substrate in a solution containing the polymers. For example, a contact lens may be placed or dipped for a suitable period of time in a solution of the hydrophilic reactive polymer or copolymer in a suitable medium, for example, an aprotic solvent such as acetonitrile.
The reaction temperature must be at least sufficient to maintain the reactants in liquid solution and is suitably less than 55°c. The reaction temperature is preferably from about 15 to about 45°c, more preferably from about 20 to about 40° c, and most preferably is approximately ambient temperature.
As indicated above, one embodiment of the invention involves the attachment of reactive hydrophilic polymers to a medical device, which polymers comprise isocyanate- containing monomeric units or ring-opening monomeric units. In one embodiment of the present invention, the ring-opening reactive monomer has an azlactone group represented by the following formula:
Figure imgf000022_0001
& wherein R3 and R4 independently can be an alkyl group having 1 to 14 carbon atoms, a cycloalkyl group having 3 to 14 carbon atoms, an aryl group having 5 to 12 ring atoms, an arenyl group having 6 to 26 carbon atoms, and 0 to 3 heteroatoms non-peroxidic selected from S, N, and O, or R3 and R taken together with the carbon to which they are joined can form a carbocyclic ring containing 4 to 12 ring atoms, and n is an integer 0 or 1. Such monomeric units are disclosed in U.S. Patent No. 5,177,165 to Valint et al.
The ring structure of such reactive functionalities is susceptible to nucleophiϋc ring-opening reactions with complementary reactive functional groups on the surface of the substrate being treated. For example, the azlactone functionality can react with primary amines, hydroxyls, or thiols in the substrate, as mentioned above, to form a covalent bond between the substrate and the hydrophilic reactive polymer at one or more locations along the polymer. A plurality of attachments can form a series of polymer loops on the substrate, wherein each loop comprises a hydrophilic chain attached at both ends to the substrate.
Azlactone-functional monomers for making the hydrophilic reactive polymer can be any monomer, prepolymer, or oligomer comprising an azlactone functionality of the above formula in combination with a vinylic group on an unsaturated hydrocarbon to which the azlactone is attached. Preferably, azlactone-functionality is provided in the hydrophilic polymer by 2-alkenyl azlactone monomers. The 2-alkenyl azlactone monomers are known compounds, their synthesis being described, for example, in U.S. Patent. Nos. 4,304,705; 5,081,197; and 5,091,489 (all Heilmann et al.) the disclosures of which are incorporated herein by reference. Suitable 2-alkenyl azlactones include:
2-ethenyl-l,3-oxazolin-5-one,
2-ethenyl-4-methyl-l,3-oxazolin-5-one,
2-isopropenyl-l,3-oxazolin-5-one,
2-isopropenyl-4-methyl-l,3-oxazolin-5-one,
2-ethenyl-4,4-dimethyl-l,3-oxazolin-5-one,
2-isopropenyl-4,-dirnethyl-l,3-oxazolin-5-one,
2-ethenyl-4-methyl-ethyl-l,3-oxazolin-5-one,
2-isopropenyl-4-methyl-4-butyl- 1 ,3-oxazolin-5-one,
2-ethenyl-4,4-dibutyl-l,3-oxazolin-5-one,
2-isopropenyl-4-methyl-4-dodecyl- 1 ,3 -oxazolin-5 -one,
2-isopropenyl-4,4-diphenyl-l,3-oxazolin-5-one,
2-isopropenyl-4,4-pentamethylene-l,3-oxazolin-5-one,
2-isopropenyl-4,4-tetramethylene-l,3-oxazolin-5-one,
2-ethenyl-4,4-diethyl-l,3-oxazolin-5-one,
2-ethenyl-4-methyl-4-nonyl-l,3-oxazolin-5-one,
2-isopropenyl-methyl-4-phenyl-l,3-oxazolin-5-one,
2-isopropenyl-4-methyl-4-benzyl-l ,3-oxazolin-5-one, and 2-ethenyl-4,4-ρentamethylene-l,3-oxazolin-5-one,
More preferably, the azlactone monomers are a compound represented by the
Figure imgf000024_0001
following general formula: where R and R^ independently denote a hydrogen atom or a lower alkyl radical with one to six carbon atoms, and R^ and R^ independently denote alkyl radicals with one to six carbon atoms or a cycloalkyl radical with five or six carbon atoms. Specific examples include 2-isopropenyl-4,4-dimethyl-2-oxazolin-5-one (TPDMO), 2-vinyl-4,4-dimethyl-2-oxazolin-5-one (VDMO), spiro-4'-(2'- isopropenyl-2'-oxazolin-5-one) cyclohexane (TPCO), cyclohexane-spiro-4'-(2'- vinyl-2'-oxazol-5'-one) (VCO), and 2-(-l-propenyl)-4,4-dimethyl-oxazol-5-one (PDMO) and the like. These compounds may be prepared by the general reaction sequence:
Figure imgf000024_0002
CICOOC2H5
Hexane
Figure imgf000024_0003
The first step is a Shotten-Bauman acylation of an amino acid. The polymerizable functionality is introduced by using either acryloyl or methacryloyl chloride. The second step involves a ring closure with a chloroformate to yield the desired oxazolinone. The product is isolated and purified by the usual procedures of organic chemistry.
As indicated above, the compounds can be copolymerized with hydrophilic and or hydrophobic comonomers to form hydrophihc reactive polymers. After attachment to the desired substrate, any unreacted oxazolinone groups may then be hydrolyzed in order to convert the oxazolinone components into amino acids. In general, the hydrolysis step will follow the general reaction of:
Figure imgf000025_0001
The carbon-carbon double bond between the R1 and R2 radicals is shown unreacted, but the reaction can take place when copolymerized into a polymer.
Non-limiting examples of comonomers useful to be copolymerized with azlactone functional moieties to form the hydrophilic reactive polymers used to coat a medical device include those mentioned above, preferably dimethylacrylamide, N-vinyl pyrrolidinone. Further examples of comonomers are disclosed in European Patent Publication 0 392 735, the disclosure of which is incorporated by reference. Preferably, dimethylacrylamide is used as a comonomer in order to impart hydrophihcity to the copolymer.
Such azlactone-functional monomers can be copolymerized with other monomers in various combinations of weight percentages. Using a monomer of similar reactivity ratio to that of an azlactone monomer will result in a random copolymer. Determination of reactivity ratios for copolymerization are disclosed in Odian, Principles of Polymerization, 2nd Ed., John Wiley & Sons, p. 425-430 (1981), the disclosure of which is incorporated by reference herein. Alternatively, use of a comonomer having a higher reactivity to that of an azlactone will tend to result in a block copolymer chain with a higher concentration of azlactone-functionality near the terminus of the chain.
Although not as preferred as monomers, azlactone-functional prepolymers or oligomers having at least one free-radically polymerizable site can also be utilized for providing azlactone-functionality in the hydrophilic reactive polymer according to the present invention. Azlactone-functional oligomers, for example, are prepared by free radical polymerization of azlactone monomers, optionally with comonomers as described in U.S. Patent Nos. 4,378,411 and 4,695,608, incorporated by reference herein. Non- limiting examples of azlactone-functional oligomers and prepolymers are disclosed in U.S. Pat. Nos. 4,485,236 and 5,081,197 and European Patent Publication 0 392 735, all incorporated by reference herein.
In another embodiment of the invention, the ring-opening reactive group in the hydrophilic reactive polymer is an epoxy functionality. The preferred epoxy-functional monomer is an oxfr ane-containing monomer such as glycidyl methacrylate, allyl glycidyl ether, 4-vinyl-l-cyclohexene-l,2-epoxide and the like, although other epoxy-containing monomers may be used.
The hydrophilic reactive polymers are attached to medical devices which may be made by conventional manufacturing processes. For example, contact lenses for application of the present invention can be manufactured employing various conventional techniques, to yield a shaped article having the desired posterior and anterior lens surfaces. Spincasting methods are disclosed in U.S. Patent Nos. 3,408,429 and 3,660,545; preferred static casting methods are disclosed in U.S. Patent Nos. 4,113,224 and 4,197,266. Curing of the monomeric mixture is often followed by a machining operation in order to provide a contact lens having a desired final configuration. As an example, U.S. Patent No. 4,555,732 discloses a process in which an excess of a monomeric mixture is cured by spincasting in a mold to form a shaped article having an anterior lens surface and a relatively large thickness. The posterior surface of the cured spincast article is subsequently lathe cut to provide a contact lens having the desired thickness and posterior lens surface. Further machining operations may follow the lathe cutting of the lens surface, for example, edge-finishing operations. After producing a lens having the desired final shape, it is desirable to remove residual solvent from the lens before edge-finishing operations. This is because, typically, an organic diluent is included in the initial monomeric mixture in order to minimize phase separation of polymerized products produced by polymerization of the monomeric mixture and to lower the glass transition temperature of the reacting polymeric mixture, which allows for a more efficient curing process and ultimately results in a more uniformly polymerized product. Sufficient uniformity of the initial monomeric mixture and the polymerized product are of particular concern for silicone hydrogels, primarily due to the inclusion of silicone-containing monomers which may tend to separate from the hydrophilic comonomer. Suitable organic diluents include, for example, 2-hydoxy, 2-methyl decane, monohydric alcohols, with C -C10 straight-chained or branched alcohols including aliphatic monohydric alcohols such as n-hexanol and n- nonanol being especially preferred. US Patent 6,020,445 to Vanderlaan et al. discloses suitable alcohols and is incorporated herein by reference. Other useful solvents include diols such as ethylene glycol; polyols such as glycerin; ethers such as diethylene glycol monoethyl ether; ketones such as methyl ethyl ketone; esters such as methyl enanthate; and hydrocarbons such as toluene. Preferably, the organic diluent is sufficiently volatile to facilitate its removal from a cured article by evaporation at or near ambient pressure. Generally, the diluent is included at five to sixty percent by weight of the monomeric mixture, with ten to fifty percent by weight being especially preferred.
The cured lens is then subjected to solvent removal, which can be accomplished by evaporation at or near ambient pressure or under vacuum. An elevated temperature can be employed to shorten the time necessary to evaporate the diluent. The time, temperature and pressure conditions for the solvent removal step will vary depending on such factors as the volatility of the diluent and the specific monomeric components, as can be readily determined by one skilled in the art. According to a preferred embodiment, the temperature employed in the removal step is preferably at least 50°C, for example, 60 to 80 °C. A series of heating cycles in a linear oven under inert gas or vacuum may be used to optimize the efficiency of the solvent removal. The cured article after the diluent removal step should contain no more than twenty percent by weight of diluent, preferably no more than five percent by weight or less.
Following removal of the organic diluent, the lens is next subjected to mold release and optional machining operations. The machining step includes, for example, buffing or polishing a lens edge and/or surface. Generally, such machining processes may be performed before or after the article is released from a mold part. Preferably, the lens is dry released from the mold by employing vacuum tweezers to lift the lens from the mold, after which the lens is transferred by means of mechanical tweezers to a second set of vacuum tweezers and placed against a rotating surface to smooth the surface or edges. The lens may then be turned over in order to machine the other side of the lens.
Subsequent to the mold release/machining operations, the lens is subjected to surface treatment according to the present invention, as described above, including the attachment of the hydrophilic reactive polymer chains.
Subsequent to the step of surface treatment, the lens may be subjected to extraction to remove residuals in the lenses. Generally, in the manufacture of contact lenses, some of the monomer mix is not fully polymerized. The incompletely polymerized material from the polymerization process may affect optical clarity or may be harmful to the eye. Residual material may include solvents not entirely removed by the previous solvent removal operation, unreacted monomers from the monomeric mixture, oligomers present as by-products from the polymerization process, or even additives that may have migrated from the mold used to form the lens.
Conventional methods to extract such residual materials from the polymerized contact lens material include extraction with an alcohol solution for several hours (for extraction of hydrophobic residual material) followed by extraction with water (for extraction of hydrophilic residual material). Thus, some of the alcohol extraction solution remains in the polymeric network of the polymerized contact lens material, and should be extracted from the lens material before the lens may be worn safely and comfortably on the eye. Extraction of the alcohol from the lens can be achieved by employing heated water for several hours. Extraction should be as complete as possible, since incomplete extraction of residual material from lenses may contribute adversely to the useful life of the lens. Also, such residuals may impact lens performance and comfort by interfering with optical clarity or the desired uniform hydrophilicity of the lens surface. It is important that the selected extraction solution in no way adversely affects the optical clarity of the lens. Optical clarity is subjectively understood to be the level of clarity observed when the lens is visually inspected.
Subsequent to extraction, the lens is subjected to hydration in which the lens is fully hydrated with water, buffered saline, or the like. When the lens is ultimately fully hydrated (wherein the lens typically may expand by 10 to about 20 percent or more), the coating remains intact and bound to the lens, providing a durable, hydrophihc coating which has been found to be resistant to delamination.
Following hydration, the lens may undergo cosmetic inspection wherein trained inspectors inspect the contact lenses for clarity and the absence of defects such as holes, particles, bubbles, nicks, tears. Inspection is preferably at 10X magnification. After the lens has passed the steps of cosmetic inspection, the lens is ready for packaging, whether in a vial, plastic blister package, or other container for maintaining the lens in a sterile condition for the consumer. Finally, the packaged lens is subjected to sterilization, which sterilization may be accomplished in a conventional autoclave, preferably under an air pressurization sterilization cycle, sometime referred to as an air-steam mixture cycle, as will be appreciated by the skilled artisan. Preferably the autoclaving is at 100° C to 200° C for a period of 10 to 120 minutes. Following sterilization, the lens dimension of the sterilized lenses may be checked prior to storage.
Examples of rigid-gas-permeable ("RGP") materials useful in the present invention include the materials prepared from sihcone-containing monomers as taught in US Patent Nos. 4,152,508; 4,330,383; 4,686,267; 4,826,889; 4,826,936; 4,861,850; 4,996,275; and 5,346,976. The teachings of these patents are expressly incorporated herein by reference. The RGP materials do not generally require solvent removal or extraction steps before they are used as substrates in accordance with the invention.
Objects and advantages of this invention are further illustrated by the following examples, but the particular materials and amounts thereof recited in these examples, as well as other conditions and details should not be construed at unduly limit this invention.
EXAMPLE 1 This example discloses a representative silicone hydrogelJens material used as a coating substrate in the following Examples. The formulation for the material is provided in Table 1 below.
TABLE 1
Figure imgf000030_0001
The following materials are designated above:
TRIS-VC tris(trimethylsiloxy)silylpropyl vinyl carbamate
ΝVP Ν-vinyl pyrrolidone
N2D25 a silicone-containing vinyl carbonate as previously described in U.S. Patent No. 5,534,604. VTNAL N-vinyloxycarbonyl alanine
Darocur Darocur- 1173 , a UV initiator tint agent l,4-bis[4-(2-memacryloxyethyl)phenylarnino] anthraquinone
EXAMPLE 2 This Example illustrates a process for preparation of a contact lens prior to surface modification of a contact lens according to the present invention. Silicone hydrogel lenses made of the formulation of Example 1 above were cast-molded from polypropylene molds. Under an inert nitrogen atmosphere, 45-μl of the formulation was injected onto a clean polypropylene concave mold half and covered with the complementary polypropylene convex mold half. The mold halves were compressed at a pressure of 70 psi and the mixture was cured for about 15 minutes in the presence of UV light (6-11 mW/cm2 as measured by a Spectronic UV meter). The mold was exposed to UV light for about 5 additional minutes. The top mold half was removed, and the lenses were maintained at 60°C for 3 hours in a forced air oven to remove n-nonanol. Subsequently, the lens edges were ball buffed for 10 seconds at 2300 rpm with a force of 60 g.
EXAMPLE 3 This example illustrates the synthesis of the hydrophilic reactive copolymer involving a 80/20 by weight percent ratio of monomers (DMA/VDMO) employing the ingredients in Table 2 below:
TABLE 2
Figure imgf000031_0001
All ingredients except VAZO-64 were placed in a 500-ml round-bottom flask equipped with a magnetic stirrer, condenser, argon blanket, and thermo-controller. The above was de-aerated with argon for 30 min. After VAZO-64 was added, the solution was heated to 60°C and maintained for 50 hrs. After the reaction was complete as monitored by FTIR (Fourier Transform Infrared spectroscopy), the solution was slowly added to 2500 ml of diethyl ether to precipitate the polymer. The mixture was stirred 10 min, allowed to settle 10 min, and filtered. The precipitate was dried under vacuum at 30 to 35°C overnight, and the molecular weight determined to be Mn = 19448, Mw = 43548 and Pd = 2.25, all based on polystyrene standards. (Pd refers to polydispersity.) EXAMPLE 4 This Example illustrates the synthesis of a prepolymer of N, N-dimethylacrylamide that is used in making a macromonomer (or "macromer") for eventual use in a reactive hydrophilic polymer according to the present invention. The prepolymer is made according to the following reaction scheme.
Reagents DMA (200 g, 2.0 moles), mercaptoethanol (3.2 g, 0.041 moles), AJJ3N (Vazo-64 in the amount 3.3 g, 0.02 moles) and tefrahychofuran (1,000 ml) were combined in a two liter round bottom flask fitted with a magnetic stirrer, condenser, thermal controller and a nitrogen inlet. Nitrogen gas was bubbled through the solution for one half-hour. The temperature was increased to 60°C for 72 hours under a passive blanket of nitrogen. The polymer was precipitated from the reaction mixture with 20 liters of ethyl ether (171.4 g of polymer was isolated). A sample submitted for SEC (size exclusion chromatography) analysis gave a Mn = 3711, Mw = 7493, and Pd = 2.02.
EXAMPLE 5 This Example illustrates the synthesis of a macromer of DMA using the prepolymer of Example 4 which macromonomer is used to make the hydrophilic reactive polymer of Examples 6 and 8 below, which macromonomer is made according to the following reaction scheme:
Figure imgf000033_0001
Figure imgf000033_0002
The prepolymer from Example 4 (150 g, 0.03 moles), isocyanatoethylmethacrylate (IEM, 5.6 g, 0.036 moles), dibutyltindilaurate (0.23 g, 3.6 xlO"5 moles), tetrahydrofuran (THF, 1000 ml) and 2,6-di-tert-butyl-4-methyl phenol (BHT, 0.002 g, 9x10" 6 moles) were combined under a nitrogen blanket. The mixture was heated to 35°C with good stirring for seven hours. Heating was stopped, and the mixture was allowed to stir under nitrogen overnight. Several ml of methanol were added to react with any remaining DEM. The macromonomer was then collected after precipitation from a large volume (16 liters) of ethyl ether. The solid was dried under house vacuum (yield 115 g). Size exclusion chromatography of the polymer verses polystyrene standards gave the following results: Mn = 2249, Mw = 2994, and Pd = 1.33.
EXAMPLE 6 This Example illustrates the preparation of a DMA DMA-mac/NDMO polymer which may be used to form a coating according to the present invention. Dimethylacrylamide (DMA) in the amount of 16 g (0J614 mole), vinyl-4,4-dimethyl-2- oxazolin-5-one (VDMO) in the amount of 2 g (0.0144 mole), dimethylacrylamide macromer (DMA-mac) as prepared in Example 5, in the amount of 2 g (0.0004 mole), and 200 ml of toluene were placed in a 500-ml round-bottom flask equipped with a magnetic stirrer, condenser, argon blanket, and temperature controller. The solution was de-aerated with argon for 30 min. Then 0.029 g (0J mole%) of VAZO-64 was added and the reaction heated to 60°C for 50 hrs. After the reaction was complete (monitored by FT1R), the solution was slowly added to 2500 ml of ethyl ether to precipitate the polymer. After the addition was complete, the mixture was stirred 10 min, allowed to settle 10 min, and filtered. The precipitate was dried under house vacuum at 30 to 35 °C overnight. The dried polymer was sampled for analysis by gel permeation chromatography, bottled and stored in a desiccator.
EXAMPLE 7 This Example illustrates the preparation of a DMA/PEOMA/VDMO polymer usable to coat a silicone substrate according to the present invention. Dimethylacrylamide, in the amount of 12 g (0J211 mole), vinyl-4,4-dimethyl-2- oxazolin-5-one in the amount of 4 g (0.0288 mole), and 4 g (0.0036 mole) PEO methacrylate (PEOMA), which monomer has a MW of 1000, and 200 ml of toluene were placed in a 500 ml round-bottom flask equipped with a magnetic stirrer, condenser, argon blanket, and temperature controller. The solution was de-aerated with argon for 30 min. Then 0.025 g (0J mole %) of VAZO-64 was added, and the reaction heated to 60°C for 50 hrs. After the reaction was complete (monitored by FTrR), the solution was slowly added to 2500 ml of ethyl ether to the polymer. After the addition was complete, the mixture was stirred 10 min, allowed to settle 10 min, and filtered. The precipitate was dried under house vacuum at 30 to 35 °C overnight. The dried polymer was sampled for analysis by gel permeation chromatography, bottled and stored in a desiccator. EXAMPLE 8 This Example illustrates the synthesis of a hydrophilic reactive polymer having a brush or branched structure with DMA chains pendent from the backbone of the polymer. The polymer consisted of the combination of the DMA macromonomer, glycidyl methacrylate, and DMA monomer, prepared as follows. To a reaction flask were added distilled N,N-dimethylacrylamide (DMA, 32g, 0.32 moles), DMA macromer from Example 5 in the amount of 4 g (0.0008 moles), distilled glycidyl methacrylate (GM, 4J g, 0.029 moles), Vazo-64 (ATBN, 0.06 g, 0.00037 moles) and toluene (500 ml). The reaction vessel was fitted with a magnetic stirrer, condenser, thermal controller, and a nitrogen inlet. Nitrogen was bubbled through the solution for 15 min to remove any dissolved oxygen. The reaction flask was then heated to 60°C under a passive blanket of nitrogen for 20 hours. The reaction mixture was then added slowly to 4 liters of ethyl ether with good mechanical stirring. The reactive polymer precipitated and was collected by vacuum filtration. The solid was placed in a vacuum oven at 30°C overnight to remove the ether, leaving 33.2 g of reactive polymer (83% yield). The reactive polymer was placed in a desiccator for storage until use.
EXAMPLE 9 This example illustrates the synthesis of a vinylpyrrrolidone-co-4- vinylcyclohexyl-l,2-epoxide polymer (NVP-co-VCH) useful to coat a silicone substrate according to the present invention. The polymer was prepared based on the following reaction scheme:
Figure imgf000035_0001
To a 1 liter reaction flask were added distilled N-vinylpyrrolidone (NVP, 53.79 g, 0.48 moles), 4-vinylcyclohexyl-l,2-epoxide (VCHE, 10.43 g , 0.084 moles), Vazo-64 (AIBN, 0.05 g, 0.0003 moles) and THF (600 ml). The reaction vessel was fitted with a magnetic stirrer, condenser, thermal controller, and a nitrogen inlet. Nitrogen was bubbled through the solution for 15 min to remove any dissolved oxygen. The reaction flask was then heated to 60°C under a passive blanket of nitrogen for 20 hrs. The reaction mixture was then added slowly to 6 liters of ethyl ether with good mechanical stirring. The copolymer precipitated and was collected by vacuum filtration. The solid was placed in a vacuum oven at 30°C overnight to remove the ether, leaving 21 g of reactive polymer (32% yield). The hydrophilic reactive polymer was placed in a desiccator for storage until use.
EXAMPLE 10 This Example illustrates the synthesis of a hydrophilic reactive (linear) copolymer of DMA/GMA, which is used in Examples 13, 14, and 15 below, according to the following reaction scheme:
Figure imgf000036_0001
Vazo-64
Figure imgf000036_0002
To a 1 -liter reaction flask were added distilled N,N-dimethylacrylamide (DMA, 48 g, 0.48 moles), distilled glycidyl methacrylate (GM, 12 g, 0.08 moles), Vazo-64 (AIBN, 0.096 g, 0.0006 moles) and toluene (600 ml). The reaction vessel was fitted with a magnetic stirrer, condenser, thermal controller, and a nitrogen inlet. Nitrogen was bubbled through the solution for 15 min to remove any dissolved oxygen. The reaction flask was then heated to 60°C under a passive blanket of nitrogen for 20 hours. The reaction mixture was then added slowly to 6 liters of ethyl ether with good mechanical stirring. The reactive polymer precipitated and was collected by vacuum filtration. The solid was placed in a vacuum oven at 30°C overnight to remove the ether leaving 50J g of reactive polymer (83% yield). The reactive polymer was placed in a desiccator for storage until use.
EXAMPLE 11
This Example illustrates the synthesis of a water-soluble reactive polymer of DMA/OFPMA/GMA, according to the following reaction scheme:
Figure imgf000037_0001
Vazo-64
Figure imgf000037_0002
To a 500 ml reaction flask were added distilled N,N-dimethylacrylamide (DMA,16 g, 0J6 moles), lH,lH,5H-octafluoroρentylmethacrylate (OFPMA,l g, 0.003 moles, used as received), distilled glycidyl methacrylate (GM, 4 g , 0.028 moles) Vazo- 64 (ATBN, 0.03 g, 0.00018 moles) and toluene (300 ml). The reaction vessel was fitted with a magnetic stirrer, condenser, thermal controller, and a nitrogen inlet. Nitrogen was bubbled through the solution for 15 minutes to remove any dissolved oxygen. The reaction flask was then heated to 60° C under a passive blanket of nitrogen for 20 hours. The reaction mixture was then added slowly to 3 liters of ethyl ether with good mechanical stirring. The reactive polymer precipitated and was collected by vacuum filtration. The solid was placed in a vacuum oven at 30°C overnight to remove the ether leaving 19.3 g of reactive polymer (92% yield). The reactive polymer was placed in a desiccator for storage until use.
EXAMPLE 12
This Example illustrates the synthesis of a hydrophilic reactive polymer of DMA/MAA, according to the following reaction scheme:
Figure imgf000039_0001
Vazo-64
Figure imgf000039_0002
To a 500 ml reaction flask were added distilled N,N-dimethylacrylamide (DMA, 16g, 0J6moles), methacrylic acid (MAA, 4 g , 0.05 moles) Vazo-64 (ATBN, 0.033 g, 0.0002 moles) and anhydrous 2-propanol (300 ml). The reaction vessel was fitted with a magnetic stirrer, condenser, thermal controller, and nitrogen inlet. Nitrogen was bubbled through the solution for 15 minutes to remove any dissolved oxygen. The reaction flask was then heated to 60°C under a passive blanket of nitrogen for 72 hours. The reaction mixture was then added slowly to 3 liters of ethyl ether with good mechanical stirring. The reactive polymer precipitated and was collected by vacuum filtration. The solid was placed in a vacuum oven at 30°C overnight to remove the ether leaving 9.5 g of reactive polymer (48 % yield). The reactive polymer was placed in a desiccator for storage until use. EXAMPLE 13
This Example illustrates the surface treatment of Balafilcon A contact lenses (Pure Vision® lenses, commercially available from Bausch & Lomb, Inc., Rochester, NY) made from the material of Example 1, which surface treatment employed the hydrophilic reactive polymers made from Example 10 above, according to the following reaction scheme:
Autoclave
Balafilcon
Figure imgf000040_0001
Figure imgf000040_0002
A solution of reactive polymer of Example 10 (10.0 g per 1000 ml of water) was prepared. Lenses were extracted with three changes of 2-propanol over a four-hour period and then with three changes of water at one-hour intervals. Lenses (36 samples) were then placed in the solution of reactive polymer. One drop of rnemyldiemanolamine was added to catalyze the reaction. The lenses were put through one 30-minute autoclave cycle. EXAMPLE 14 This Example illustrates the surface treatment of an RGP Lens Surface according to the present invention, as shown below. The material was Boston® XO (hexafocon A) lens, commercially available from Bausch & Lomb, Inc.
Triethanolamine
Figure imgf000041_0001
Procedure: The reactive polymer used in this Example 14 was dimethylacrylamide-co-glycidyl methacrylate [DMA-co-GMA where x=68 mole % and y= 32 mole %] and the substrate was the Boston XO® rigid gas permeable material. The reaction scheme is given in figure I above. Two polymer solutions were prepared as follows; Solution A was prepared by combining 3 grams of the reactive polymer and 1.3 grams of methyldiemanolamine with 65 ml of purified water. Solution B was prepared by combining 1.6 grams of the reactive polymer and 1.3 grams of methyldiethanolamine with 65 ml of purified water. RGP lenses were first cleaned with Boston Advance® and then placed in 5 ml of polymer solution. Half the samples were left standing over night and half were placed in an oven at 55°C for one hour. All treated samples were rinsed twice with HPLC grade water and allowed to dry.
A Physical Electronics [PHI] Model 5600 XPS was used for the surface characterization. This instrument utilized a monochromated Al anode operated a 300 watts, 15kV and 20 milliamps. The base pressure of the instrument was 2.0 x 10 "10 torr and during operation the pressure was 5.0 x 10"8 torr. This instrument made use of a hemispherical analyzer. The instrument had an Apollo workstation with PHI 8503A version 4.0A software. The practical measure for sampling depth for this instrument at a sampling angle of 45° was 74A.
Each specimen was analyzed utilizing a low-resolution survey spectra (0- HOOeV) to identify the elements present on the sample surface (10-lOθA). Surface elemental compositions were determined from high-resolution spectra obtained on the elements detected in the low-resolution survey scans. Those elements included oxygen, nitrogen, carbon, silicon and fluorine. Quantification of elemental compositions was completed by integration of the photoelectron peak areas after sensitizing those areas with the instrumental transmission function and atomic cross sections for the orbitals of interest. The XPS data for the coated lenses and controls are given in Table 3 below. These data show that the lenses are coated with the nitrogen-containing polymers. The nitrogen level increases from 0J (=0) to >5.5 percent while the fluorine and sihcone levels drop. The fluorine ratio was calculated as follows; [F] con^HF] test÷ [F]C0ntI0l. The value represents the amount of fluorine covered up by the coating polymer, where 1= 100% covered. The silicone ratio was calculated in a similar manner [Si] conta)ι-[Si] test ÷ [Si]Controi- Thus these data further suggest that the substrates were nearly completely covered by the coating polymer.
TABLE 3
XPS Data for Coated RGP Lenses of Example IN
FileComment Cls Nls Ols Fls [F] Ratio [Si] Ratio CONTROLS
AVERAGE 56.25 0.14 19.32 18.94 0.00 0.00
ST.DEV. 0.8 0.2 0.5 0.5
P-C RGP @ ROOM TEMP DMA/GMA 5%
AVERAGE 70.22 5.55 22.67 0.71 0.96 0.85
ST.DEV. 1.4 0.3 0.7 0.6
P-C RGP @ 55 C DMA/GMA 5%
AVERAGE 71.81 5.52 22.37 0.00 1.00 0.94
ST. DENJ 0.8 0.5 0.5 0.0
P-C RGP @ ROOM TEMP DMA/GMA 2.5%
AVERAGE 69.61 5.08 22.72 1.63 0.91 0.82
ST. DEV. 1.3 0.3 0.5 0.5
P-C RGP @ 55 C DMA/GMA 2.5%
AVERAGE 70.75 5.52 23.04 0.43 0.98 0.96
ST.DEV. 0.5 0.4 0.6 0.3
EXAMPLE 15 This Example illustrates another surface treatment of an Boston® XO contact lens material, commercially available from Bausch & Lomb, Inc., according to the following reaction sequence:
Figure imgf000044_0001
Triethar arrine
Figure imgf000044_0002
TABLE 4
XPS Data for Room Temperature Coating of Boston XO lenses of Example 15
[C] [O] [N] [Si] [F] [F] Ratio
Control MEAN 55.3 19.3 0.4 5.5 19.7 0.00 no rub SD 0.4 0.7 0.2 0.4 0.4
Sample A MEAN 72.4 17.3 8.5 0.6 1.2 0.94 room temp.-no rub SD 2.0 0.8 1.5 0.9 1.6
Sample B MEAN 69.4 18.1 6.7 2.0 3.9 0.80 room temp.-no rub SD 2.2 0.3 1.0 0.8 2.2
Sample C MEAN 69.6 17.9 8.7 1.4 2.5 0.88 room temp.-no rub SD 1.8 1.1 2.3 1.0 1.7
[C] [O] [N] [S] [F]
Control MEAN 55.1 19.5 0.6 6.9 18.1 0.00 l rub SD 0.0 0.1 0.2 0.1 0.4
Sample A MEAN 66.3 21.0 5.0 4.0 3.5 0.81 room temp.-l rub SD 1.0 0.5 0.5 0.7 1.0
Sample B MEAN 67.2 19.9 5.6 3.5 3.8 0.79 room temp.-l rub SD 3.1 0.9 1.1 1.9 1.6
Sample C MEAN 66.1 20.8 5.2 2.8 5.0 0.73 room temp.-l rub SD 2.2 1.2 0.7 0.9 2.6
Sample D 57.7 18.9 1.1 5.8 16.6 0.08 no cat-with 1 rub 1.4 0.4 0.6 0.9 1.6
EXAMPLE 16
The material substrate for this experiment was the Boston XO® lens. The reaction scheme is shown above in Example 15. Two solutions of reactive polymers were prepared. The first was a solution of DMA86moIe%-co-GMA14mole% (3 g /60 ml of water). The second solution was prepared by mixing DMA76mole%-co-MAA24mole% (3 g / 60 ml of water) and methyldiethanolamine (2.5 g/ 60 ml of water). The two solutions were passed through a Millipore 5 -micron type LS membrane filter and then combined to give a mixed solution of 5% polymer by weight. Boston XO® lenses were then placed in the 5 ml of reactive polymer mixture and allowed to stand for 4, 8 and 16 hours. The lenses were then rinsed off twice with purified water and submitted for XPS and TOF- SDVIS analyses.
Autoclav
Figure imgf000046_0001
Figure imgf000046_0002
The XPS data is given below. Clearly the lenses are coated with the nitrogen- containing polymer even after rubbing the samples with purified water. The fluorine ratio was calculated as follows; [F] ctratror[F] test ÷ [^-control- The value represents the amount of fluorine covered up by the coating polymer, where 1= 100% covered.
TABLE 5 XPS Data for Room Temperature Coating of Boston XO lenses of Example VI
FileComment Cls Nls Ols Fls Si2p [F] Ratio CONTROLS
AVERAGE 54.88 0.10 19.25 19.78 5.99 0.00 ST.DEV. 0.5 0.1 0.2 0.8 0.4
CONTROLS CLEANED
AVERAGE 61.17 3.37 19.68 17.93 5.42 0.00
ST.DEV. 1.1 0.3 2.4 4.4 0.2
P-C RGP LENSES 4 HR.
AVERAGE 61.17 3.37 19.68 11.31 4.47 0.37
ST.DEV. 1.1 0.3 0.2 0.8 0.4
P-C RGP LENSES 8 HR.
AVERAGE 62.72 4.35 20.32 7.54 5.07 0.58
ST.DEV. 1.7 0.9 0.7 0.9 1.9
P-C RGP LENSES 16 HR.
AVERAGE 62.57 4.38 19.93 8.21 4.92 0.54
ST.DEV. 0.9 0.4 0.6 1.4 1.2
EXAMPLE 18
Procedure:
A solution was prepared, of reactive polymer, N,N-dimethylacrylamide-co-glycidyl methacrylate (0.4 g/ 20 ml of HPLC water) and eight drops of triethanolamine. Polished buttons (4 samples) were imaged by non-contact atomic force microscopy then cleaned by rubbing with HPLC grade water. The substrates were then placed in the 4-5 ml of reactive polymer solution, in sealed lens flat packs and heated to 55°C for one hour. The treated polymer buttons were then rinsed off twice with HPLC water and allowed to dry. A drop of water placed on an untreated lens would bead up and roll off the surface while a drop of water was placed on the treated lens spread completely wetting the lens surface. The buttons were then cleaned with 3-4 drops of Boston® Advance brand contact lens cleaner, a sterile surfactant solution containing silica gel as an abrasive-cleaning agent, followed by rinsing (2 times with) HPLC grade water. The polymer buttons were allowed to dry and AFM images were again recorded. The images appeared to be equivalent to those taken before any coating was applied.
The coating procedure outlined above was repeated and AFM images were recorded. The material again appeared to be coated with polymer.
The procedure of this Example 18 was repeated with three fresh RGP contact lens material buttons. Surface analysis for the repeated experiment was x-ray photoelectron spectroscopy (XPS). The XPS data is given in the table below. It is clearly evident from the data given below, looking at the increase of nitrogen (N, from the coating polymer) and the corresponding decreases of silicon (Si) and fluorine (F) in the substrate, that the polymer coating was applied, removed and applied again.
TABLE 6 XPS Results for Example 18
Figure imgf000049_0001
Figure 7 is an AFM topographical image (50 μm2) of an RGP contact lens material button of Example 18 prior to surface treatment.
Figure 8 is an AFM topographical image (50 μm2) of the surface of an RGP button after a first hydrophilic polymer coating step in Example 18.
Figure 9 is an AFM topographical image (50 μm2) of the surface of an RGP button after abrasive removal of the polymer coating in Example 18.
Figure 10 is an AFM topographical image (50 μm2) of the surface of an RGP button after the hydrophilic polymeric surface was re-applied in Example 18. EXAMPLE 19
This Example illustrates the synthesis of the monomer 12-methacryloyloxydodecanoic acid useful in the synthesis of reactive polymers. A reference can be found in the U.S. Patent 4,485,045 by Regen entitled "Sythetic Phosphatidyl Cholines Useful in Forming Liposomes".
Figure imgf000050_0001
THF
To a 2 liter reaction flask were added 12-hydroxydodecanoic acid (99.5 g, 0.46 moles), anhydrous pryidine (56 ml) and anhydrous tetrahydrofuran (1,000 ml). The mixture was cooled in an ice bath to 0°C. A solution of distilled methacryloyl chloride (48g, 0.046 moles) in anhydrous tetrahydrofuran (200 ml) was slowly added to the cold reaction mixture with good stirring. Following the addition the mixture was allowed to reach room temperature and left stirring overnight. The solvent was removed by flash evaporation and the residue was taken up in 1 liter of ethyl ether. The ether solution was washed with purified water, dried over magnesium sulfate and again flash evaporated leaving 98.5 grams of crude product. The crude product was further purified by silica gel chromatography using a 1:2 mixture of ethylacetate and heptane to give a 63 % yield.
EXAMPLE 20
Example 20 illustrates the synthesis of a hydrophilic reactive polymer of N,N- dimethylacrylamide -co- 12-methacryloyloxydodecanoic acid. EXAMPLE 21
This Example illustrates the synthesis of a hydrophilic reactive polymer of N,N- dimethylacrylamide -co-octafluoropentyl methacrylate-co- 12- methacryloyloxydodecanoic acid.
Figure imgf000051_0001
Figure imgf000051_0002
Figure imgf000051_0003
To a 500 ml reaction flask were added distilled N,N-dimethylacrylamide (DMA, 15 g, 0J51 moles), lH,lH,5H-octafluoropentylmethacrylate (OFPMA 0.5g, 0.0016 moles, used as received), 12-methacryloxydodecanoic acid (LMAA, 4.5 g, 0.0158 moles) Vazo
50 64 (AIBN, 0.032g, 0.0002 moles) and anhydrous tetrahydrofuran (200 ml). The reaction vessel was fitted with a magnetic stirrer, condenser, thermal controller and a nitrogen inlet. Nitrogen was bubbled through the solution for 15 minutes to remove any dissolved oxygen. The reaction flask was then heated to 60° C under a passive blanket of nitrogen for 72 hours. The reaction mixture was then added slowly to 2.5L of heptane with good mechanical stirring. The reactive polymer precipitated and was collected by vacuum filtration. The solid was placed in a vacuum oven at 30°C overnight to remove the ether leaving 18.7g of reactive polymer (94 % yield). The reactive polymer was placed in a desiccator for storage until use.
EXAMPLE 22
Example 22 illustrates the synthesis of a hydrophilic reactive polymer of N,N- dimethylacrylamide -co-laurylmethacrylate-co-glycidyl methacrylate.
51
Figure imgf000053_0001
1.5 mole %
Vazo 64 THF
Figure imgf000053_0002
To a 1000 ml reaction flask were added distilled N,N-dimethylacrylamide (DMA,32, g, 0.32 moles), laurylmethacyy;ate (LMA, 1.5 g, 0.006 moles, used as received), distilled glycidyl methacrylate (GM, 8 g , 0.056 moles) Vazo-64 (ATBN, 0.06g, 0.00036 moles) and tetrahydrofuran (600 ml). The reaction vessel was fitted with a magnetic stirrer, condenser, thermal controller and a nitrogen inlet. Nitrogen was bubbled through the solution for 15 minutes to remove any dissolved oxygen. The reaction flask was then heated to 60° C under a passive blanket of nitrogen for 20 hours. The reaction mixture was then added slowly to 3 L of ethyl ether with good mechanical stirring. The reactive polymer precipitated and was collected by vacuum filtration. The solid was placed in a
52 vacuum oven at 30°C overnight to remove the ether leaving 29.2 g of reactive polymer (70 % yield). The reactive polymer was placed in a desiccator for storage until use.
Many other modifications and variations of the present invention are possible in light of the teachings herein. It is therefore understood that, within the scope of the claims, the present invention can be practiced other than as herein specifically described.
53

Claims

1. A method for treating the surface of a medical device comprising:
(a) forming a medical device from a material comprising monomeric units having reactive functionalities selected from the group consisting of azlactone, carboxylic acid, amine, hydroxy and epoxy functionalities, and combinations thereof;
(b) forming a hydrophilic reactive polymer having complementary reactive functionalities along the polymer chain selected from the group comprising azlactone, isocyanate, acid anhydride, epoxy, hydroxy, primary or. secondary amine, or carboxylic acid functionalities, and combinations thereof, wherein in the case of the hydroxy or amine complementary reactive functionalities, the material comprises azlactone reactive functionalities and in the case of the carboxylic acid complementary functionality, the material comprises epoxy reactive functionalities;
(c) reacting the hydrophilic reactive polymer of (b) having complementary reactive functionalities along the polymer chain with said reactive functionalities on or near the surface of the medical device of (a), at a reaction temperature at least sufficient to maintain the reactants in solution and less than 55°c, thus forming a biocompatible surface on the medical device;
(d) removing the biocompatible surface of step (c); and
(e) repeating steps (b) and (c) to form a renewed biocompatible surface on said medical device having properties substantially similar to the original biocompatible surface of step (c).
2. The method of claim 1, wherein the medical device is a silicone contact lens or intraocular lens and the coating is uncolored.
54
3. The method of claim 1, wherein the medical device is a silicone hydrogel, continuous-wear contact lens.
4. The method of claim 1, wherein the hydrophilic reactive polymer comprises 1 to 100 mole percent of monomeric units having said reactive functionalities.
5. The method of claim 1, wherein the hydrophilic reactive polymer comprises 0 to 99 mole percent of monomeric units that are derived from non-reactive hydrophilic monomers.
6. The method of claim 1, wherein the polymer comprises 50 to 95 mole percent of monomeric units derived from non-reactive hydrophilic monomers selected from the group consisting of acrylamides, lactones, poly(alkylenepoxy)methacrylates, methacrylic acid or hydroxyalkyl methacrylates and 5 to 50 percent of monomeric units derived from functionally reactive monomers selected from the group consisting of epoxy, azlactone, and anhydride containing monomers, wherein the alkyl or alkylene groups have 1 to 6 carbon atoms.
7. The method of claim 1, wherein the functionally reactive monomers are selected from the group consisting of glycidyl methacrylate, maleic anhydride, itaconic anhydride, and isocyanomethacrylate.
8. The method of claim 1, wherein the hydrophihc monomers are selected from the group consisting of dimethylacrylamide, acrylamide, N-vinyl pyrrohdinone methacrylic acid.
9. The method of claim 1, wherein the hydrophilic reactive polymer comprises 0 to 35 mole percent monomeric units derived from hydrophobic monomers.
10. The method of claim 1, wherein the hydrophilic polymer comprises oxazolinone moieties having the following formula:
55
Figure imgf000057_0001
O wherein R3 and R4 independently can be an alkyl group having 1 to 14 carbon atoms; a cycloalkyl group having 3 to 14 carbon atoms; an aryl group having 5 to 12 ring atoms; an arenyl group having 6 to 26 carbon atoms; and 0 to 3 heteroatoms selected from S, N, and nonperoxidic 0; or R3 and R taken together with the carbon to which they are joined can form a carbocyclic ring containing 4 to 12 ring atoms, and n is an integer 0 or 1.
11. The method of claim 10, wherein the polymer comprises the reaction product of a mixture of monomers comprising the monomer represented by the general formula:
°'
Figure imgf000057_0002
where Rl and R2 independently denote a hydrogen atom or a lower alkyl radical with one to six carbon atoms, and R^ and R^ independently denote alkyl radicals with one to six carbon atoms or a cycloalkyl radicals with 5 or 6 carbon atoms.
12. The method of claim 11, wherein the monomer is selected from the group consisting of 2-vinyl-4, 4-dimethyl-2-oxazolin-5-one; 2-isopropenyl-4,4- dimethyl-2-oxazolin-5-one; 2-isopropenyl-4 ,4-dimethyl-2-oxazolin-5-one; and 2- vinyl-4,4-dimethyl-2-oxazol in-5 -one.
56
13. The method of claim 10, wherein the medical device is dipped in a solution comprising at least one hydrophilic reactive polymer in the absence of a coloring substance.
14. The method of claim 1 wherein said removing step (d) further comprises abrading said biocompatible surface.
15. The method of claim 3 wherein said removing step (d) further comprises abrading said biocompatible surface with an abrasive particulate in an aqueous carrier solution.
16. The method of claim 15 wherein said abrasive particulate comprises silica or alumina.
17. The method of claim 1 wherein said reaction temperature is from about 15 to about 45°c.
18. The method of claim 17 where in said reaction temperature is from about 20 to about 40°c.
19. The method of claim 18 wherein said reaction temperature is approximately ambient temperature.
57
PCT/US2001/023028 2000-09-19 2001-07-20 Method for applying polymeric lens coating WO2002024793A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP2002529197A JP2004512866A (en) 2000-09-19 2001-07-20 Method for applying a polymer lens coating
EP01961687A EP1319037A1 (en) 2000-09-19 2001-07-20 Method for applying polymeric lens coating
MXPA03002322A MXPA03002322A (en) 2000-09-19 2001-07-20 Method for applying polymeric lens coating.
KR1020037003878A KR100766642B1 (en) 2000-09-19 2001-07-20 Method for applying polymeric lens coating
CNB01815946XA CN1266197C (en) 2000-09-19 2001-07-20 Method for applying polymeric lens coating
AU2001282933A AU2001282933A1 (en) 2000-09-19 2001-07-20 Method for applying polymeric lens coating
BR0114212-7A BR0114212A (en) 2000-09-19 2001-07-20 Method for treating the surface of a medical device
CA002420861A CA2420861C (en) 2000-09-19 2001-07-20 Method for applying polymeric lens coating

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66535500A 2000-09-19 2000-09-19
US09/665,355 2000-09-19

Publications (1)

Publication Number Publication Date
WO2002024793A1 true WO2002024793A1 (en) 2002-03-28

Family

ID=24669789

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/023028 WO2002024793A1 (en) 2000-09-19 2001-07-20 Method for applying polymeric lens coating

Country Status (11)

Country Link
US (1) US6638563B2 (en)
EP (1) EP1319037A1 (en)
JP (1) JP2004512866A (en)
KR (1) KR100766642B1 (en)
CN (1) CN1266197C (en)
AU (1) AU2001282933A1 (en)
BR (1) BR0114212A (en)
CA (1) CA2420861C (en)
MX (1) MXPA03002322A (en)
TW (1) TW552286B (en)
WO (1) WO2002024793A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005531365A (en) * 2002-06-28 2005-10-20 ボシュ・アンド・ロム・インコーポレイテッド Surface modified intraocular lens
JP2006513282A (en) * 2002-12-17 2006-04-20 ボシュ・アンド・ロム・インコーポレイテッド Surface treatment of medical devices
WO2006092002A1 (en) * 2005-03-01 2006-09-08 Carl Zeiss Vision Australia Holdings Ltd Coatings for ophthalmic lens elements
US8222358B2 (en) 2006-03-02 2012-07-17 Exxonmobil Chemical Patents Inc. Process for producing propylene copolymers
AU2012200550B2 (en) * 2005-03-01 2013-09-19 Carl Zeiss Vision Australia Holdings Limited Coatings for ophthalmic lens elements
JP2014523542A (en) * 2011-06-09 2014-09-11 ノバルティス アーゲー Silicone hydrogel lens with nanotextured surface

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030165015A1 (en) * 2001-12-05 2003-09-04 Ocular Sciences, Inc. Coated contact lenses and methods for making same
US7270678B2 (en) * 2002-06-28 2007-09-18 Bausch & Lomb Incorporated Surface modification of functional group-containing medical devices with catalyst-containing reactive polymer system
US20050065438A1 (en) * 2003-09-08 2005-03-24 Miller Landon C.G. System and method of capturing and managing information during a medical diagnostic imaging procedure
US7722808B2 (en) 2003-09-12 2010-05-25 Novartis Ag Method and kits for sterilizing and storing soft contact lenses
US20060068224A1 (en) * 2004-09-30 2006-03-30 George Grobe Coated biomedical device and associated method
US9297928B2 (en) 2004-11-22 2016-03-29 Johnson & Johnson Vision Care, Inc. Ophthalmic compositions comprising polyether substituted polymers
US20060260956A1 (en) * 2005-05-23 2006-11-23 Bausch & Lomb Incorporated Methods for preventing or reducing interaction between packaging materials and polymeric articles contained therein
US7163446B1 (en) 2005-06-20 2007-01-16 John Ray Cole Vehicle headlight restoration
ES2407821T3 (en) * 2006-05-09 2013-06-14 Carl Zeiss Vision Australia Holdings Ltd. Methods for forming high index coated optical elements
US20070264509A1 (en) * 2006-05-11 2007-11-15 Yu-Chin Lai Copolymer and Medical Device with the Copolymer
US20080143955A1 (en) * 2006-12-15 2008-06-19 Bausch & Lomb Incorporated Silicone Contact Lenses with Silicate Coating
US7625598B2 (en) * 2006-12-15 2009-12-01 Bausch & Lomb Incorporated Silicone contact lenses with wrinkled surface
US8147897B2 (en) * 2007-02-09 2012-04-03 Novartis Ag Cross-linkable polyionic coatings for medical devices
US20080206481A1 (en) * 2007-02-26 2008-08-28 Bausch & Lomb Incorporated Silicone contact lenses with wrinkled surface
JP5840823B2 (en) * 2007-03-30 2016-01-06 株式会社朝日ラバー Lens and lighting apparatus having the same
US20080259617A1 (en) * 2007-04-19 2008-10-23 Wayne M. Torcivia Transportation system and method or methods for the restoration,re-manufacturing and re-conditioning or any combination thereof,of a vehicle headlight fixture or headlight fixture lens or any combination thereof
KR100883415B1 (en) * 2007-07-04 2009-02-11 조광페인트주식회사 Anti-fogging paint composition and thermosetting acrylic polymer used for it
CN101896514B (en) * 2007-12-14 2013-03-06 博士伦公司 Biomedical devices
WO2009079223A1 (en) 2007-12-14 2009-06-25 Bausch & Lomb Incorporated Surface modified biomedical devices
US8049061B2 (en) 2008-09-25 2011-11-01 Abbott Cardiovascular Systems, Inc. Expandable member formed of a fibrous matrix having hydrogel polymer for intraluminal drug delivery
US8076529B2 (en) 2008-09-26 2011-12-13 Abbott Cardiovascular Systems, Inc. Expandable member formed of a fibrous matrix for intraluminal drug delivery
US8500687B2 (en) 2008-09-25 2013-08-06 Abbott Cardiovascular Systems Inc. Stent delivery system having a fibrous matrix covering with improved stent retention
US8226603B2 (en) 2008-09-25 2012-07-24 Abbott Cardiovascular Systems Inc. Expandable member having a covering formed of a fibrous matrix for intraluminal drug delivery
US8163358B2 (en) * 2009-02-18 2012-04-24 Synergeyes, Inc. Surface modification of contact lenses
EP2638879A3 (en) 2010-07-30 2018-05-16 Novartis AG Silicone hydrogel lenses with water-rich surfaces
HUE029018T2 (en) 2011-10-12 2017-02-28 Novartis Ag Method for making uv-absorbing ophthalmic lenses by coating
US8798332B2 (en) 2012-05-15 2014-08-05 Google Inc. Contact lenses
US9158133B1 (en) 2012-07-26 2015-10-13 Google Inc. Contact lens employing optical signals for power and/or communication
US9523865B2 (en) 2012-07-26 2016-12-20 Verily Life Sciences Llc Contact lenses with hybrid power sources
US9298020B1 (en) 2012-07-26 2016-03-29 Verily Life Sciences Llc Input system
US8857981B2 (en) 2012-07-26 2014-10-14 Google Inc. Facilitation of contact lenses with capacitive sensors
US8919953B1 (en) 2012-08-02 2014-12-30 Google Inc. Actuatable contact lenses
US9696564B1 (en) 2012-08-21 2017-07-04 Verily Life Sciences Llc Contact lens with metal portion and polymer layer having indentations
US9111473B1 (en) 2012-08-24 2015-08-18 Google Inc. Input system
US9395468B2 (en) 2012-08-27 2016-07-19 Ocular Dynamics, Llc Contact lens with a hydrophilic layer
US8820934B1 (en) 2012-09-05 2014-09-02 Google Inc. Passive surface acoustic wave communication
US20140192315A1 (en) 2012-09-07 2014-07-10 Google Inc. In-situ tear sample collection and testing using a contact lens
US9398868B1 (en) 2012-09-11 2016-07-26 Verily Life Sciences Llc Cancellation of a baseline current signal via current subtraction within a linear relaxation oscillator-based current-to-frequency converter circuit
US10010270B2 (en) 2012-09-17 2018-07-03 Verily Life Sciences Llc Sensing system
US9326710B1 (en) 2012-09-20 2016-05-03 Verily Life Sciences Llc Contact lenses having sensors with adjustable sensitivity
US8960898B1 (en) 2012-09-24 2015-02-24 Google Inc. Contact lens that restricts incoming light to the eye
US8870370B1 (en) 2012-09-24 2014-10-28 Google Inc. Contact lens that facilitates antenna communication via sensor impedance modulation
US8979271B2 (en) 2012-09-25 2015-03-17 Google Inc. Facilitation of temperature compensation for contact lens sensors and temperature sensing
US8989834B2 (en) 2012-09-25 2015-03-24 Google Inc. Wearable device
US20140088372A1 (en) 2012-09-25 2014-03-27 Google Inc. Information processing method
US9884180B1 (en) 2012-09-26 2018-02-06 Verily Life Sciences Llc Power transducer for a retinal implant using a contact lens
US8960899B2 (en) 2012-09-26 2015-02-24 Google Inc. Assembling thin silicon chips on a contact lens
US8821811B2 (en) 2012-09-26 2014-09-02 Google Inc. In-vitro contact lens testing
US8985763B1 (en) 2012-09-26 2015-03-24 Google Inc. Contact lens having an uneven embedded substrate and method of manufacture
US9063351B1 (en) 2012-09-28 2015-06-23 Google Inc. Input detection system
US8965478B2 (en) 2012-10-12 2015-02-24 Google Inc. Microelectrodes in an ophthalmic electrochemical sensor
US9176332B1 (en) 2012-10-24 2015-11-03 Google Inc. Contact lens and method of manufacture to improve sensor sensitivity
US9757056B1 (en) 2012-10-26 2017-09-12 Verily Life Sciences Llc Over-molding of sensor apparatus in eye-mountable device
MY172901A (en) 2012-12-17 2019-12-13 Alcon Inc Method for making improved uv-absorbing ophthalmic lenses
US9498035B2 (en) 2012-12-21 2016-11-22 Coopervision International Holding Company, Lp Silicone hydrogel contact lenses for sustained release of beneficial polymers
US8874182B2 (en) 2013-01-15 2014-10-28 Google Inc. Encapsulated electronics
US9289954B2 (en) 2013-01-17 2016-03-22 Verily Life Sciences Llc Method of ring-shaped structure placement in an eye-mountable device
US20140209481A1 (en) 2013-01-25 2014-07-31 Google Inc. Standby Biasing Of Electrochemical Sensor To Reduce Sensor Stabilization Time During Measurement
US9636016B1 (en) 2013-01-25 2017-05-02 Verily Life Sciences Llc Eye-mountable devices and methods for accurately placing a flexible ring containing electronics in eye-mountable devices
US9161712B2 (en) 2013-03-26 2015-10-20 Google Inc. Systems and methods for encapsulating electronics in a mountable device
US9113829B2 (en) 2013-03-27 2015-08-25 Google Inc. Systems and methods for encapsulating electronics in a mountable device
US20140371560A1 (en) 2013-06-14 2014-12-18 Google Inc. Body-Mountable Devices and Methods for Embedding a Structure in a Body-Mountable Device
US9084561B2 (en) 2013-06-17 2015-07-21 Google Inc. Symmetrically arranged sensor electrodes in an ophthalmic electrochemical sensor
US9948895B1 (en) 2013-06-18 2018-04-17 Verily Life Sciences Llc Fully integrated pinhole camera for eye-mountable imaging system
US9685689B1 (en) 2013-06-27 2017-06-20 Verily Life Sciences Llc Fabrication methods for bio-compatible devices
US9492118B1 (en) 2013-06-28 2016-11-15 Life Sciences Llc Pre-treatment process for electrochemical amperometric sensor
US9307901B1 (en) 2013-06-28 2016-04-12 Verily Life Sciences Llc Methods for leaving a channel in a polymer layer using a cross-linked polymer plug
US9814387B2 (en) 2013-06-28 2017-11-14 Verily Life Sciences, LLC Device identification
US9028772B2 (en) 2013-06-28 2015-05-12 Google Inc. Methods for forming a channel through a polymer layer using one or more photoresist layers
EP3570093B1 (en) 2013-11-15 2021-09-15 Tangible Science, Inc. Contact lens with a hydrophilic layer
EP3083216B1 (en) 2013-12-17 2018-01-31 Novartis AG A silicone hydrogel lens with a crosslinked hydrophilic coating
US9572522B2 (en) 2013-12-20 2017-02-21 Verily Life Sciences Llc Tear fluid conductivity sensor
US9654674B1 (en) 2013-12-20 2017-05-16 Verily Life Sciences Llc Image sensor with a plurality of light channels
US9366570B1 (en) 2014-03-10 2016-06-14 Verily Life Sciences Llc Photodiode operable in photoconductive mode and photovoltaic mode
US9184698B1 (en) 2014-03-11 2015-11-10 Google Inc. Reference frequency from ambient light signal
US9789655B1 (en) 2014-03-14 2017-10-17 Verily Life Sciences Llc Methods for mold release of body-mountable devices including microelectronics
FR3023381B1 (en) * 2014-07-03 2016-08-12 Essilor Int OPHTHALMIC LENS HAVING ANTIFOULING PROPERTIES DIFFERENTIATED ON ITS TWO FACES AND METHODS OF MANUFACTURE
MY183678A (en) 2014-08-26 2021-03-08 Alcon Inc Method for applying stable coating on silicone hydrogel contact lenses
US10525170B2 (en) 2014-12-09 2020-01-07 Tangible Science, Llc Medical device coating with a biocompatible layer
EP3391101B1 (en) 2015-12-15 2020-07-08 Alcon Inc. Method for applying stable coating on silicone hydrogel contact lenses
EP3438144B1 (en) * 2016-03-31 2021-06-30 Toray Industries, Inc. Copolymer, wetting agent, medical device, and method for producing same
US10830923B2 (en) 2017-12-13 2020-11-10 Alcon Inc. Method for producing MPS-compatible water gradient contact lenses
JP2022164588A (en) * 2021-04-16 2022-10-27 ペガヴィジョン コーポレーション Contact lens and manufacturing method therefor
CN115975479B (en) * 2023-01-06 2023-06-27 东北石油大学 Method for preparing durable underwater super-oleophobic coating by using phase separation method

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0328340A2 (en) * 1988-02-09 1989-08-16 BAUSCH &amp; LOMB INCORPORATED Hydrophilic oxygen permeable polymers
EP0338656A2 (en) * 1988-02-09 1989-10-25 BAUSCH &amp; LOMB INCORPORATED Polymeric silicone-based materials with high oxygen permeability
WO1998028026A1 (en) * 1996-12-23 1998-07-02 Novartis Ag Reactive coatings
WO1999057177A1 (en) * 1998-05-05 1999-11-11 Bausch & Lomb Incorporated Plasma surface treatment of silicone hydrogel contact lenses
EP0989418A2 (en) * 1998-09-23 2000-03-29 JOHNSON &amp; JOHNSON VISION PRODUCTS, INC. Wettable silicone-based lenses
WO2000072052A1 (en) * 1999-05-20 2000-11-30 Bausch & Lomb Incorporated Surface treatment of medical devices with reactive hydrophilic polymers
WO2000071613A1 (en) * 1999-05-20 2000-11-30 Bausch & Lomb Incorporated Surface treatment of silicone hydrogel contact lenses comprising hydrophilic polymer chains attached to an intermediate carbon coating
WO2001074932A1 (en) * 2000-04-03 2001-10-11 Bausch & Lomb Incorporated Surface treatment of silicone medical devices

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL137711C (en) 1961-12-27
NL128305C (en) 1963-09-11
US4197266A (en) 1974-05-06 1980-04-08 Bausch & Lomb Incorporated Method for forming optical lenses
US4113224A (en) 1975-04-08 1978-09-12 Bausch & Lomb Incorporated Apparatus for forming optical lenses
US4136250A (en) 1977-07-20 1979-01-23 Ciba-Geigy Corporation Polysiloxane hydrogels
US4153641A (en) 1977-07-25 1979-05-08 Bausch & Lomb Incorporated Polysiloxane composition and contact lens
US4152508A (en) 1978-02-15 1979-05-01 Polymer Technology Corporation Silicone-containing hard contact lens material
US4330383A (en) 1978-07-18 1982-05-18 Polymer Technology Corporation Dimensionally stable oxygen permeable hard contact lens material and method of manufacture
US4826889A (en) 1978-07-18 1989-05-02 Polymer Technology, Corp. Dimensionally stable oxygen permeable hard contact lens material and method of manufacture
US4304705A (en) 1980-01-02 1981-12-08 Minnesota Mining And Manufacturing Company Radiation-curable polymers containing pendant unsaturated peptide groups derived from azlactone polymers
US4378411A (en) 1980-01-02 1983-03-29 Minnesota Mining And Manufacturing Company Radiation-curable polymers
US4826936A (en) 1981-12-04 1989-05-02 Polymer Technology Corp. Silicone-containing contact lens material and contact lenses made thereof
US4604479A (en) 1981-12-04 1986-08-05 Polymer Technology Corporation Silicone-containing contact lens material and contact lenses made thereof
US4463149A (en) 1982-03-29 1984-07-31 Polymer Technology Corporation Silicone-containing contact lens material and contact lenses made thereof
US4485236A (en) 1982-09-27 1984-11-27 Minnesota Mining And Manufacturing Company Azlactone-functional compounds
US4555732A (en) 1984-03-22 1985-11-26 Xerox Corporation Image sensor correction system
US4695608A (en) 1984-03-29 1987-09-22 Minnesota Mining And Manufacturing Company Continuous process for making polymers having pendant azlactone or macromolecular moieties
JPS60259269A (en) * 1984-06-04 1985-12-21 テルモ株式会社 Medical device and its production
US4686267A (en) 1985-10-11 1987-08-11 Polymer Technology Corporation Fluorine containing polymeric compositions useful in contact lenses
US4996275A (en) 1985-10-11 1991-02-26 Polymer Technology Corporation Fluorine containing polymeric compositions useful in contact lenses
US4861850A (en) 1986-02-06 1989-08-29 Progressive Chemical Research, Ltd. Ophthalamic device from fluoro-silicon polymers
US4740533A (en) 1987-07-28 1988-04-26 Ciba-Geigy Corporation Wettable, flexible, oxygen permeable, substantially non-swellable contact lens containing block copolymer polysiloxane-polyoxyalkylene backbone units, and use thereof
US4734475A (en) 1986-12-15 1988-03-29 Ciba-Geigy Corporation Wettable surface modified contact lens fabricated from an oxirane containing hydrophobic polymer
US5292840A (en) 1987-03-13 1994-03-08 Minnesota Mining And Manufacturing Company Polymeric supports
US4954587A (en) 1988-07-05 1990-09-04 Ciba-Geigy Corporation Dimethylacrylamide-copolymer hydrogels with high oxygen permeability
US5070215A (en) 1989-05-02 1991-12-03 Bausch & Lomb Incorporated Novel vinyl carbonate and vinyl carbamate contact lens material monomers
US5034461A (en) 1989-06-07 1991-07-23 Bausch & Lomb Incorporated Novel prepolymers useful in biomedical devices
US5177168A (en) 1989-10-17 1993-01-05 Polymer Technology Corp. Polymeric compositions useful in oxygen permeable contact lenses
US5032658A (en) 1989-10-17 1991-07-16 Polymer Technology Corporation Polymeric compositions useful in oxygen permeable contact lenses
US5079319A (en) 1989-10-25 1992-01-07 Ciba-Geigy Corporation Reactive silicone and/or fluorine containing hydrophilic prepolymers and polymers thereof
US5010141A (en) 1989-10-25 1991-04-23 Ciba-Geigy Corporation Reactive silicone and/or fluorine containing hydrophilic prepolymers and polymers thereof
US5206298A (en) * 1989-12-19 1993-04-27 Tomei Sangyo Kabushiki Kaisha Graft copolymer, solution containing the graft copolymer for treating contact lens, and method of treating contact lens with the solution and making hydrophilic lens surface
US5091489A (en) 1990-10-23 1992-02-25 Minnesota Mining And Manufacturing Company Oligo (2-alkenyl azlactones)
US5081197A (en) 1990-10-23 1992-01-14 Minnesota Mining And Manufacturing Company Oligo(2-alkenyl azlactones)
US5219965A (en) 1990-11-27 1993-06-15 Bausch & Lomb Incorporated Surface modification of polymer objects
US5177165A (en) 1990-11-27 1993-01-05 Bausch & Lomb Incorporated Surface-active macromonomers
GB9113875D0 (en) * 1991-06-27 1991-08-14 Biointeractions Ltd Polymer coatings
CA2116849C (en) 1991-09-12 2001-06-12 Yu-Chin Lai Wettable silicone hydrogel compositions and methods
US5310779A (en) 1991-11-05 1994-05-10 Bausch & Lomb Incorporated UV curable crosslinking agents useful in copolymerization
US5358995A (en) 1992-05-15 1994-10-25 Bausch & Lomb Incorporated Surface wettable silicone hydrogels
US5260000A (en) 1992-08-03 1993-11-09 Bausch & Lomb Incorporated Process for making silicone containing hydrogel lenses
US5336797A (en) 1992-12-30 1994-08-09 Bausch & Lomb Incorporated Siloxane macromonomers
US5321108A (en) 1993-02-12 1994-06-14 Bausch & Lomb Incorporated Fluorosilicone hydrogels
US5346976A (en) 1993-03-29 1994-09-13 Polymer Technology Corporation Itaconate copolymeric compositions for contact lenses
US5451651A (en) 1993-12-17 1995-09-19 Bausch & Lomb Incorporated Urea and urethane monomers for contact lens materials
US5760100B1 (en) 1994-09-06 2000-11-14 Ciba Vision Corp Extended wear ophthalmic lens
JP3647093B2 (en) * 1994-11-17 2005-05-11 株式会社メニコン Hydrophilized oxygen permeable contact lens and method for producing the same
US5804318A (en) * 1995-10-26 1998-09-08 Corvita Corporation Lubricious hydrogel surface modification
JPH09263795A (en) * 1996-03-29 1997-10-07 Tomey Technol Corp Cleaning solution for contact lens and method for cleaning contact lens therewith
US5708094A (en) 1996-12-17 1998-01-13 Bausch & Lomb Incorporated Polybutadiene-based compositions for contact lenses
US6020445A (en) 1997-10-09 2000-02-01 Johnson & Johnson Vision Products, Inc. Silicone hydrogel polymers
US5981669A (en) 1997-12-29 1999-11-09 Bausch & Lomb Incorporated Silicone-containing prepolymers and low water materials

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0328340A2 (en) * 1988-02-09 1989-08-16 BAUSCH &amp; LOMB INCORPORATED Hydrophilic oxygen permeable polymers
EP0338656A2 (en) * 1988-02-09 1989-10-25 BAUSCH &amp; LOMB INCORPORATED Polymeric silicone-based materials with high oxygen permeability
WO1998028026A1 (en) * 1996-12-23 1998-07-02 Novartis Ag Reactive coatings
WO1999057177A1 (en) * 1998-05-05 1999-11-11 Bausch & Lomb Incorporated Plasma surface treatment of silicone hydrogel contact lenses
EP0989418A2 (en) * 1998-09-23 2000-03-29 JOHNSON &amp; JOHNSON VISION PRODUCTS, INC. Wettable silicone-based lenses
WO2000072052A1 (en) * 1999-05-20 2000-11-30 Bausch & Lomb Incorporated Surface treatment of medical devices with reactive hydrophilic polymers
WO2000071613A1 (en) * 1999-05-20 2000-11-30 Bausch & Lomb Incorporated Surface treatment of silicone hydrogel contact lenses comprising hydrophilic polymer chains attached to an intermediate carbon coating
WO2001074932A1 (en) * 2000-04-03 2001-10-11 Bausch & Lomb Incorporated Surface treatment of silicone medical devices

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
VALINT P L ET AL: "SURFACE-ACTIVE MACROMONOMERS FOR COATING OF CONTACT LENS POLYMERS", POLYMERIC MATERIALS SCIENCE AND ENGINEERING, WASHINGTON, DC, US, vol. 76, 13 April 1997 (1997-04-13), pages 93 - 94, XP000931173, ISSN: 0743-0515 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005531365A (en) * 2002-06-28 2005-10-20 ボシュ・アンド・ロム・インコーポレイテッド Surface modified intraocular lens
JP2006513282A (en) * 2002-12-17 2006-04-20 ボシュ・アンド・ロム・インコーポレイテッド Surface treatment of medical devices
WO2006092002A1 (en) * 2005-03-01 2006-09-08 Carl Zeiss Vision Australia Holdings Ltd Coatings for ophthalmic lens elements
AU2012200550B2 (en) * 2005-03-01 2013-09-19 Carl Zeiss Vision Australia Holdings Limited Coatings for ophthalmic lens elements
US8550623B2 (en) 2005-03-01 2013-10-08 Carl Zeiss Vision Australia Holdings, Ltd. Coatings for ophthalmic lens elements
US8222358B2 (en) 2006-03-02 2012-07-17 Exxonmobil Chemical Patents Inc. Process for producing propylene copolymers
JP2014523542A (en) * 2011-06-09 2014-09-11 ノバルティス アーゲー Silicone hydrogel lens with nanotextured surface

Also Published As

Publication number Publication date
KR100766642B1 (en) 2007-10-15
BR0114212A (en) 2003-12-23
CN1461325A (en) 2003-12-10
US6638563B2 (en) 2003-10-28
MXPA03002322A (en) 2003-06-24
CN1266197C (en) 2006-07-26
CA2420861C (en) 2007-04-24
KR20030036797A (en) 2003-05-09
AU2001282933A1 (en) 2002-04-02
JP2004512866A (en) 2004-04-30
TW552286B (en) 2003-09-11
EP1319037A1 (en) 2003-06-18
US20030068433A1 (en) 2003-04-10
CA2420861A1 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
CA2420861C (en) Method for applying polymeric lens coating
EP1268621B1 (en) Surface treatment of silicone medical devices
EP1179190B1 (en) Surface treatment of medical devices with reactive hydrophilic polymers
EP1187873B1 (en) Surface treatment of silicone hydrogel contact lenses comprising hydrophilic polymer chains attached to an intermediate carbon coating

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2001961687

Country of ref document: EP

Ref document number: 2420861

Country of ref document: CA

Ref document number: 00251/DELNP/2003

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2001282933

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: PA/a/2003/002322

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1020037003878

Country of ref document: KR

Ref document number: 2002529197

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 01815946X

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 1020037003878

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2001961687

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642